Office of the Commissioner of Lobbying of Canada Office of the Commissioner of Lobbying of Canada

Language selection

Registry of Lobbyists

Registration - In-house Corporation

Hoffmann-La Roche Limited / BRIGITTE NOLET, PRESIDENT AND CHIEF EXECUTIVE OFFICER

Registration Information

In-house Corporation name: Hoffmann-La Roche Limited
Previous in-house corporation names
Responsible Officer Name: BRIGITTE NOLET, PRESIDENT AND CHIEF EXECUTIVE OFFICER 
Responsible Officer Change History
Initial registration start date: 2001-01-18
Registration status: Active
Registration Number: 952745-64

Associated Communications

Total Number of Communication Reports: 452

Monthly communication reports in the last 6 months: 20

Version 1 of 65 (2001-01-18 to 2002-01-30)

Version 1 of 65 (2001-01-18 to 2002-01-30) was submitted prior to the Lobbying Act coming into force on July 2, 2008. Due to different information requirements at that time, the registration is presented in the following format.

A. Information about Lobbyist and Corporation

Corporation: HOFFMANN-LA ROCHE LIMITED
2455 MEADOWPINE BLVD.
MISSISSAUGA, ON  L5N 6L7
Canada
Telephone number: 905-542-5555
Fax number: 905-542-7130  
Responsible officer name and position during the period of this registration: RONNIE MILLER, PRESIDENT AND CEO  
Description of activities: PHARMACEUTICALS, VITAMINS & FINE CHEMICALS, DIAGNOSTICS, FLAVOURS AND FEED PRE-MIXES
 
The client is a subsidiary of the following parent companies: F. HOFFMANN-LA ROCHE LIMITED
POSTFACH 4002
BASEL
Switzerland

Coalition The corporation is not a member of a coalition.
Subsidiary: The corporation does not have any subsidiaries that could be affected by the outcome of the undertaking.
Other direct interests The corporation's activities are not controlled or directed by another individual, organization or corporation with a direct interest in the outcome of this undertaking.
 
Was the corporation funded in whole or in part by any domestic or foreign government institution in the last completed financial year? No
 

B. Lobbying Activity Information

Federal departments or organizations which have been or will be communicated with during the course of the undertaking: Health Canada (HC), Industry Canada
Communication techniques that have been used or are expected to be used in the course of the undertaking:
Meetings, Written communications, whether in hard copy or electronic format
 
Subject Matter: Areas of Concern: Health, Intellectual Property, International Relations
 
Subject Matter: Particulars: BILLS OR RESOLUTIONS RE: REVIEW OF DRUG PATENT LEGISLATION (FORMERLY BILL C-91)



Responsible Officer Name

This is the responsible officer name as provided in the most recent registration for the corporation or organization.

Name Change History:

Hoffmann-La Roche Limited

The following names have been used on or after July 2, 2008

The following names have been used on or after July 2, 2008
Name From To
Hoffmann-La Roche Limited 2024-04-05 current
Hoffmann-La Roche Limited 2008-08-13 2024-04-05

The following names have been used before July 2, 2008

  • Hoffmann-La Roche Limited
  • HOFFMANN-LA ROCHE LIMITED

Responsible Officer Change History

Hoffmann-La Roche Limited

Responsible Officer History
Responsible Officer Name From (YYYY-MM-DD) To (YYYY-MM-DD)
BRIGITTE NOLET 2022-08-01 Current
RONNIE MILLER 2001-01-18 2022-08-01

All Monthly Communication Reports for Hoffmann-La Roche Limited

BRIGITTE NOLET, PRESIDENT AND CHIEF EXECUTIVE OFFICER (Corporation)

Learn more...

Registrants are required to submit a monthly communication report for each oral and arranged communication with a designated public office holder. The name of the most senior paid officer (i.e. the registrant) will appear on all in-house monthly communication reports, whether or not he/she participated in the communication.

Note: Monthly Communication Reports are due on the 15th day of each month for communications that took place in the previous month.

Results below are sorted by posted date, beginning with the most recent.

Results 1-452 of 452

  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Eshan Naik, Director of Policy | Minister's office | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2024-07-25
    Posted date: 2024-08-12
    Communication number: 64-612393 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Sophie Sommerer, Director General, Biologic and Radiopharmaceutical Drugs Directorate, Health Products and Food Branch | BRDD | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2024-07-10
    Posted date: 2024-08-12
    Communication number: 64-612394 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Judith Seidman, Senator | Senate of Canada

    Subject Matter of the communication: Economic Development, Health
    Communication date: 2024-06-27
    Posted date: 2024-07-10
    Communication number: 64-610099 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Ritu Banerjee, Assistant Deputy Minister | Director General's Office | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Economic Development
    Communication date: 2024-06-25
    Posted date: 2024-07-10
    Communication number: 64-610098 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Josh Dadjo, Director of Parliamentary Affairs | Senate of Canada

    Subject Matter of the communication: Economic Development, Health
    Communication date: 2024-06-12
    Posted date: 2024-07-10
    Communication number: 64-610096 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Rosemary Moodie, Senator | Senate of Canada

    Subject Matter of the communication: Health, Economic Development
    Communication date: 2024-06-12
    Posted date: 2024-07-09
    Communication number: 64-609890 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Simon Kennedy, Deputy Minister | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Health
    Communication date: 2024-05-24
    Posted date: 2024-06-17
    Communication number: 64-608847 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Blaine Calkins, Member of Parliament | House of Commons
    • Ed Dreeshan, Member of Parliament | House of Commons
    • Yves Giroux, Parliamentary Budget Officer | House of Commons

    Subject Matter of the communication: Health
    Communication date: 2024-05-23
    Posted date: 2024-06-17
    Communication number: 64-608848 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Josh Dadjo, Director of Parliamentary Affairs | Senate of Canada
    • Kiara Nazon, Parliamentary Research Assistant | Senator Moodie's Office | Senate of Canada

    Subject Matter of the communication: Health
    Communication date: 2024-05-10
    Posted date: 2024-06-17
    Communication number: 64-608846 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Jaxson Khan, Sr Policy Advisor | MINISTER OF INNOVATION, SCIENCE AND INDUSTRY | Innovation, Science and Economic Development Canada (ISED)
    • Laurel Chester, Senior Advisor | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Economic Development
    Communication date: 2024-04-16
    Posted date: 2024-05-10
    Communication number: 64-602725 (amended from 64-602685) View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Colin Deacon, Senator | Senate of Canada
    • David Dlab, Director of Parliamentary Affairs | Office of the Senator Colin Deacon | Senate of Canada

    Subject Matter of the communication: Health
    Communication date: 2024-04-16
    Posted date: 2024-05-10
    Communication number: 64-602684 (amended from 64-602682) View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Mark Schaan, Senior Assistant Deputy Minister | Strategy and Innovation Policy Sector - Assistant Deputy Minister's Office | Innovation, Science and Economic Development Canada (ISED)
    • Francis Bilodeau, Associate Deputy Minister | Office of the Associate Deputy Minister | Innovation, Science and Economic Development Canada (ISED)
    • Andrea Johnston, Assistant Deputy Minister | Innovation Canada | Innovation, Science and Economic Development Canada (ISED)
    • Etienne-Rene Massie, Assistant Deputy Minister | Small Business, Tourism and Marketplace Services | Innovation, Science and Economic Development Canada (ISED)
    • Brian Masse, MP for Windsor West, Ontario, and NDP Critic for Innovation, Science and Industry | House of Commons

    Subject Matter of the communication: Science and Technology
    Communication date: 2024-04-15
    Posted date: 2024-05-10
    Communication number: 64-602681 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Alison McConnell, Deputy Director | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Economic Development
    Communication date: 2024-04-11
    Posted date: 2024-05-10
    Communication number: 64-602730 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Jocelyn Milburn, Director | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Economic Development
    Communication date: 2024-04-11
    Posted date: 2024-05-10
    Communication number: 64-602729 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Ritu Banerjee, Assistant Deputy Minister | Director General's Office | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Economic Development
    Communication date: 2024-04-11
    Posted date: 2024-05-10
    Communication number: 64-602728 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Eshan Naik, Director of Policy | Minister's office | Health Canada (HC)

    Subject Matter of the communication: International Trade
    Communication date: 2024-04-09
    Posted date: 2024-05-10
    Communication number: 64-602727 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Chris Johnston, Assistant Deputy Minister | Health Canada (HC)
    • Ritu Banerjee, Assistant Deputy Minister | Director General's Office | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Internal Trade
    Communication date: 2024-04-03
    Posted date: 2024-05-10
    Communication number: 64-602726 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Ajay Rakhra, Senior Advisor | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Health
    Communication date: 2024-03-22
    Posted date: 2024-04-12
    Communication number: 64-599831 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Jocelyn Milburn, Director | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Health
    Communication date: 2024-03-21
    Posted date: 2024-04-12
    Communication number: 64-599828 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Anita Anand, President of the Treasury Board | President's Office | Treasury Board Of Canada Secretariat (TBS)

    Subject Matter of the communication: Health
    Communication date: 2024-03-15
    Posted date: 2024-04-12
    Communication number: 64-598551 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Eshan Naik, Director of Policy | Minister's office | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2024-03-07
    Posted date: 2024-04-12
    Communication number: 64-599826 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Amitpal Singh Basati, Senior Advisor | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Economic Development
    Communication date: 2024-02-28
    Posted date: 2024-03-13
    Communication number: 64-596767 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Adam Van Koeverden, Member of Parliament | House of Commons
    • Tim Uppal, Member of Parliament | Economic Development | House of Commons

    Subject Matter of the communication: Economic Development
    Communication date: 2024-02-27
    Posted date: 2024-03-13
    Communication number: 64-596764 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Tom Kmiec, Member of Parliament | House of Commons

    Subject Matter of the communication: Health
    Communication date: 2024-02-27
    Posted date: 2024-03-13
    Communication number: 64-596761 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Eshan Naik, Director of Policy | Minister's office | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2024-02-26
    Posted date: 2024-03-13
    Communication number: 64-596760 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Caroline Ménard, Manager | Office of Life Sciences and Biomanufacturing Readiness | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Health
    Communication date: 2024-02-23
    Posted date: 2024-03-13
    Communication number: 64-596759 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Ritu Banerjee, Assistant Deputy Minister | Director General's Office | Innovation, Science and Economic Development Canada (ISED)
    • Stéphane Lessard, Exe Director, Science & Technology & Inovation | Global Affairs Canada (GAC)
    • Zoe Hawa, Deputy Director, Life Science | Global Affairs Canada (GAC)

    Subject Matter of the communication: Health
    Communication date: 2023-12-07
    Posted date: 2023-12-20
    Communication number: 64-589405 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Francesco Sorbara, Member of Parliment | House of Commons
    • Tom Kmiec, Member of Parliament | House of Commons

    Subject Matter of the communication: Health
    Communication date: 2023-12-06
    Posted date: 2023-12-20
    Communication number: 64-589404 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Daniel MacDonald, Director General, Drugs for Rare Diseases | Strategic Policy Branch | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2023-11-29
    Posted date: 2023-12-13
    Communication number: 64-587185 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Sébastien Lemire, Member of Parliament | House of Commons

    Subject Matter of the communication: Health
    Communication date: 2023-11-08
    Posted date: 2023-12-13
    Communication number: 64-587184 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Eshan Naik, Director of Policy | Office of the Leader of the Government in the House of Commons | House of Commons
    • Rechie Valdez, Member of Parliament | House of Commons
    • Chris Zhou, Policy Advisor | Innovation, Science and Economic Development Canada (ISED)
    • Jennifer Miller, Assistant Secretary | Privy Council Office (PCO)
    • Jeff Waring, Associate Assistant Secretary | Privy Council Office (PCO)
    • Alexis Conrad, Assistant Secretary to the Cabinet | Privy Council Office (PCO)

    Subject Matter of the communication: Health
    Communication date: 2023-11-07
    Posted date: 2023-12-13
    Communication number: 64-587182 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Suzy McDonald, Associate Deputy Minister | Agriculture and Agri-Food Canada (AAFC)
    • Josh Dadjo, Director of Parliamentary Affairs | Senate of Canada
    • Ben Chin, Senior Advisor | Prime Minister's Office (PMO)

    Subject Matter of the communication: Health
    Communication date: 2023-11-06
    Posted date: 2023-12-13
    Communication number: 64-587178 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Eshan Naik, Director of Policy | Office of the Leader of the Government in the House of Commons | House of Commons
    • Dr. Stephen Ellis, Member of Parliament | House of Commons

    Subject Matter of the communication: Health
    Communication date: 2023-11-02
    Posted date: 2023-12-13
    Communication number: 64-587176 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Andrew Taylor, Director, Policy, Research and Data | Health Canada (HC)
    • Jennifer Grandy, Director | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2023-10-25
    Posted date: 2023-11-14
    Communication number: 64-583189 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Rodrigo Arancibia, Director, Life Science Industries Directorate | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Health
    Communication date: 2023-10-24
    Posted date: 2023-11-14
    Communication number: 64-583187 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Rodrigo Arancibia, Director, Life Science Industries Directorate | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Health
    Communication date: 2023-10-16
    Posted date: 2023-11-14
    Communication number: 64-583183 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Darryl Patterson, Director General | Innovation, Science and Economic Development Canada (ISED)
    • Rodrigo Arancibia, Director, Life Science Industries Directorate | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Health
    Communication date: 2023-10-12
    Posted date: 2023-11-14
    Communication number: 64-583176 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Cameron Yung, Policy Advisor (Western Office, Heath) | Health Canada (HC)
    • Ophelia John, Senior Policy Advisor | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2023-10-03
    Posted date: 2023-11-14
    Communication number: 64-583169 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Daniel MacDonald, Director General, Drugs for Rare Diseases | Strategic Policy Branch | Health Canada (HC)
    • Andrew Taylor, Director | Health Canada (HC)
    • Josee LeBlanc, Senior Policy Analyst | Health Canada (HC)
    • Ritu Banerjee, Assistant Deputy Minister | Director General's Office | Innovation, Science and Economic Development Canada (ISED)
    • Darryl Patterson, Director General | Innovation, Science and Economic Development Canada (ISED)
    • Mark Schaan, Assistant Deputy Minister, Strategy & Innovation Policy Sector | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Health
    Communication date: 2023-09-26
    Posted date: 2023-10-15
    Communication number: 64-579309 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Daniel MacDonald, Director General, Drugs for Rare Diseases | Strategic Policy Branch | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2023-09-21
    Posted date: 2023-10-15
    Communication number: 64-579306 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Christopher Johnstone, Assistant Deputy Minister | Covid-19 Task Force | Health Canada (HC)
    • Ryan Sigouin, Manager | Health Canada (HC)
    • Simon Kennedy, Deputy Minister | Innovation, Science and Economic Development Canada (ISED)
    • Darryl Patterson, Director General | Innovation, Science and Economic Development Canada (ISED)
    • Rodrigo Arancibia, Director, Life Science Industries Directorate | Innovation, Science and Economic Development Canada (ISED)
    • Kasondra White, Director of Strategy | Innovation, Science and Economic Development Canada (ISED)
    • Heather Earle, Manager | OLSBR | Innovation, Science and Economic Development Canada (ISED)
    • Lynn Berrouard, Senior Analyst | OLSBR | Innovation, Science and Economic Development Canada (ISED)
    • Joel Denis, Director General | Public Health Agency of Canada (PHAC)

    Subject Matter of the communication: Health
    Communication date: 2023-09-20
    Posted date: 2023-10-15
    Communication number: 64-579295 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Stephen Ellis, Member of Parliament - Cumberland - Colchester | House of Commons

    Subject Matter of the communication: Health
    Communication date: 2023-08-03
    Posted date: 2023-10-03
    Communication number: 64-577498 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Daniel MacDonald, Director General, Drugs for Rare Diseases | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2023-08-01
    Posted date: 2023-10-03
    Communication number: 64-577497 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Ritu Banerjee, Assistant Deputy Minister | Director General's Office | Innovation, Science and Economic Development Canada (ISED)
    • Darryl Patterson, Director General | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Health
    Communication date: 2023-07-07
    Posted date: 2023-08-11
    Communication number: 64-574209 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Leigh Chapman, Chief Nursing Officer | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2023-07-03
    Posted date: 2023-08-11
    Communication number: 64-574208 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Tom Kmiec, Member of Parliament | House of Commons

    Subject Matter of the communication: Health
    Communication date: 2023-06-23
    Posted date: 2023-07-13
    Communication number: 64-572120 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Adam Van Koeverden, Member of Parliament | House of Commons
    • Wilson Miao, Member of Parliament | House of Commons

    Subject Matter of the communication: Health
    Communication date: 2023-06-22
    Posted date: 2023-07-13
    Communication number: 64-572114 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Fillmore Andy, Parliamentary Secretary | Innovation, Science and Economic Development Canada (ISED)
    • Bianca Hossein, Policy Advisor | Innovation, Science and Economic Development Canada (ISED)
    • Banerjee Ritu, Asst Deputy Minister | Office of Life Sciences and Biomanufacturing Readiness | Innovation, Science and Economic Development Canada (ISED)
    • Darryl Patterson, Director General | Innovation, Science and Economic Development Canada (ISED)
    • Arancibia Rodrigo, Senior Director | Innovation, Science and Economic Development Canada (ISED)
    • White Kasondra, Director | Innovation, Science and Economic Development Canada (ISED)
    • Menard Caroline , Manager | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Health
    Communication date: 2023-06-05
    Posted date: 2023-07-13
    Communication number: 64-572100 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Francesco Sorbara, Member of Parliment | House of Commons

    Subject Matter of the communication: Health
    Communication date: 2023-05-31
    Posted date: 2023-06-15
    Communication number: 64-570173 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Bianca Hossain, Policy Advisor | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Health
    Communication date: 2023-05-31
    Posted date: 2023-06-15
    Communication number: 64-570168 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Jean-Yves Duclos, Minister of Health | Health Canada (HC)
    • Sandenga Yeba, Senior Policy Advisor | Office of the Minister of Health | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2023-05-03
    Posted date: 2023-09-20
    Communication number: 64-577115 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Stephen Ellis, Member of Parliament | House of Commons

    Subject Matter of the communication: Health
    Communication date: 2023-04-25
    Posted date: 2023-05-12
    Communication number: 64-565052 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Daniel MacDonald, Director General, Drugs for Rare Diseases, Health Canada | Health Canada (HC)
    • Michelle Mujoomdar, Director, Office of Pharmaceuticals Management Strategies, Health Canada | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2023-03-28
    Posted date: 2023-04-15
    Communication number: 64-563049 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Bruno Rodrigue, Executive Director, Office of Legislative and Regulatory Modernization | Health Canada (HC)
    • Debra Haltrecht, Office of Legislative and Regulatory Modernization (OLRM), Policy, Planning and International Affairs Directorate (PPIAD) | Health Canada (HC)
    • Diane Forbes, Manager Policy Development | Health Canada (HC)
    • Ed Morgan, Director General Policy, Planning International | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2023-03-28
    Posted date: 2023-04-15
    Communication number: 64-563040 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Chris Zhou, Policy Advisor to the Minister of International Trade, Export Promotion, Small Business and Economic Development | Global Affairs Canada (GAC)

    Subject Matter of the communication: Health
    Communication date: 2023-03-08
    Posted date: 2023-04-17
    Communication number: 64-563145 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Sandenga Yeba, Senior Policy Advisor | Minister's Office | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2023-03-08
    Posted date: 2023-04-15
    Communication number: 64-563047 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Glenn Purves, Assistant Deputy Minister | Economic Development Branch | Finance Canada (FIN)
    • Mathew Sajkunovic, Senior Director, Industry & Knowledge Economy, Finance Canada | Finance Canada (FIN)
    • Cody Burdett, Senior Director, Industry & Knowledge Economy, Finance Canada | Finance Canada (FIN)

    Subject Matter of the communication: Health
    Communication date: 2023-03-07
    Posted date: 2023-04-15
    Communication number: 64-563045 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Stephen Lucas, Deputy Minister | Health Canada (HC)
    • Eric Belair, Associate Assistant Deputy Minister, Strategic Policy Branch, Health Canada | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Health
    Communication date: 2023-03-06
    Posted date: 2023-04-15
    Communication number: 64-563044 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Michelle Boudreau, Executive Director, Office of Pharmaceutical Management Strategies, Health Canada | Office of Pharmaceutical Management Strategies | Health Canada (HC)
    • Eric Belair, Associate Assistant Deputy Minister, Strategic Policy Branch, Health Canada | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Health
    Communication date: 2023-03-06
    Posted date: 2023-04-15
    Communication number: 64-563042 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Simon Kennedy, Deputy Minister | Innovation, Science and Economic Development Canada (ISED)
    • Darryl Patterson, Director General | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Health
    Communication date: 2023-02-10
    Posted date: 2023-03-15
    Communication number: 64-559603 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Leslie Church, Chief of Staff to the Deputy Minister | Ministry of Finance | Finance Canada (FIN)

    Subject Matter of the communication: Health
    Communication date: 2023-02-06
    Posted date: 2023-03-15
    Communication number: 64-559600 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Mohamed-Iqbal Ravalia, Senator | Senate of Canada

    Subject Matter of the communication: Health
    Communication date: 2023-01-31
    Posted date: 2023-02-20
    Communication number: 64-557089 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Francesco Sorbara, Member of Parliment | Minister of National Revenue | House of Commons

    Subject Matter of the communication: Health
    Communication date: 2023-01-30
    Posted date: 2023-02-20
    Communication number: 64-557088 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Jean-Yves Duclos, Minister of Health | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2022-12-07
    Posted date: 2023-01-15
    Communication number: 64-553996 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Stephen Lucas, Deputy Minister | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2022-12-06
    Posted date: 2023-01-15
    Communication number: 64-553993 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Sandenga Yeba, Senior Policy Advisor | Minister's Office | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2022-12-01
    Posted date: 2023-01-15
    Communication number: 64-553995 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Douglas Clark, Executive Director | Patented Medicine Prices Review Board (PMPRB)

    Subject Matter of the communication: Health
    Communication date: 2022-11-29
    Posted date: 2022-12-13
    Communication number: 64-550229 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Jason Easton, Chief of Staff | Minister of International Trade | Global Affairs Canada (GAC)
    • Zachary Nixon, Senior Advisor | Office of the Minister of International Trade, Export Promotion, Small Business and Economic Dev | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Health
    Communication date: 2022-11-16
    Posted date: 2022-12-13
    Communication number: 64-550221 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Eric Costen, Assistant Deputy Minister | Innovation, Science and Economic Development Canada (ISED)
    • Darryl Patterson, Director General | Innovation, Science and Economic Development Canada (ISED)
    • Eric Belair, Assistant Deputy Minister | Innovation, Science and Economic Development Canada (ISED)
    • Sara Wilshaw, Chief Trade Commissioner | Innovation, Science and Economic Development Canada (ISED)
    • Michael Rosu-Myles, Director, Centre for Oncology | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Health
    Communication date: 2022-11-16
    Posted date: 2022-12-13
    Communication number: 64-550213 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • François-Philippe Champagne, Minister of Innovation, Sciences and Economic Development | Minister's Office | Innovation, Science and Economic Development Canada (ISED)
    • Bianca Hossain, Policy Advisor | Innovation, Science and Economic Development Canada (ISED)
    • Eric Costen, Assistant Deputy Minister | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Health
    Communication date: 2022-11-16
    Posted date: 2022-12-13
    Communication number: 64-550211 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Rechie Valdez, Member of Parliament | MP Mississauga - Streetsville | House of Commons

    Subject Matter of the communication: Health
    Communication date: 2022-09-29
    Posted date: 2022-10-13
    Communication number: 64-543570 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Rechie Valdez, Member of Parliament | MP Mississauga - Streetsville | House of Commons

    Subject Matter of the communication: Health
    Communication date: 2022-09-28
    Posted date: 2022-10-13
    Communication number: 64-543568 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Michael Collins, Assistant Deputy Minister, Testing, Tracing and Data Strategy Secretariat (COVID-19) | Covid-19 Testing Secretariat | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2022-09-15
    Posted date: 2022-10-13
    Communication number: 64-543566 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Michael Sabia, Deputy Minister of Finance | Finance Canada (FIN)

    Subject Matter of the communication: Economic Development
    Communication date: 2022-09-14
    Posted date: 2022-10-14
    Communication number: 64-543827 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Collins Michael, Associate Assistant Deputy Minister | Covid-19 Testing, Tracing and Data Strategy Secretariat | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2022-08-30
    Posted date: 2022-09-09
    Communication number: 64-541016 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Michael Colliins, Associate Assistant Deputy Minister | Covid-19 Testing, Tracing and Data Strategy Secretariat | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2022-07-22
    Posted date: 2022-08-18
    Communication number: 64-540367 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Simon Kennedy, Deputy Minister | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Industry
    Communication date: 2022-06-28
    Posted date: 2022-07-15
    Communication number: 64-538105 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Stephen Lucas, Deputy Minister | Health Canada (HC)

    Subject Matter of the communication: Industry
    Communication date: 2022-06-27
    Posted date: 2022-07-15
    Communication number: 64-538104 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Laila Goodridge, Member of Parliament | Federal Economic Development Agency for Southern Ontario (FedDev)

    Subject Matter of the communication: Health
    Communication date: 2022-06-02
    Posted date: 2022-07-15
    Communication number: 64-538096 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Sébastien Aubertin-Giguère, Assistant Deputy Minister | Covid-19 Task Force | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2022-06-02
    Posted date: 2022-07-15
    Communication number: 64-538094 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Sébastien Aubertin-Giguère, Assistant Deputy Minister | Covid-19 Task Force | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2022-06-01
    Posted date: 2022-07-15
    Communication number: 64-538091 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Jamie Kippen, Chief of Staff | Minister's Office | Health Canada (HC)
    • Jean-Sebastien Boch, Director of Policy for the Minster of Health | Health Canada (HC)
    • Stephen Ellis, Member of Parliament | House of Commons
    • Adam Van Koeverden, Member of Parliament | House of Commons

    Subject Matter of the communication: Health
    Communication date: 2022-05-31
    Posted date: 2022-06-11
    Communication number: 64-533870 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Sébastien Aubertin-Giguère, Assistant Deputy Minister | Covid-19 Task Force | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2022-05-31
    Posted date: 2022-06-11
    Communication number: 64-533867 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Tom Kmiec, Member of Parliament | House of Commons
    • Michelle Boudreau, Executive Director | Office of Pharmaceutical Management Strategies | Health Canada (HC)
    • Eric Costen, Assistant Deputy Minister | Innovation, Science and Economic Development Canada (ISED)
    • Darryl Patterson, Director General | Innovation, Science and Economic Development Canada (ISED)
    • Kasondra White, Director of Strategy | Innovation, Science and Economic Development Canada (ISED)
    • Rodrigo Arancibia, Director, Life Science Industries Directorate | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Health
    Communication date: 2022-05-30
    Posted date: 2022-06-11
    Communication number: 64-533869 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Sébastien Aubertin-Giguère, Assistant Deputy Minister | Covid-19 Task Force | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2022-05-26
    Posted date: 2022-06-11
    Communication number: 64-533866 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Carol Hughes, Member of Parliament | House of Commons

    Subject Matter of the communication: Health
    Communication date: 2022-05-17
    Posted date: 2022-06-11
    Communication number: 64-533868 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Sébastien Aubertin-Giguère, Assistant Deputy Minister | Covid-19 Task Force | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2022-05-13
    Posted date: 2022-06-11
    Communication number: 64-533865 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Matthew Jones, Assistant Deputy Minister | Covid-19 Task Force | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2022-04-21
    Posted date: 2022-05-17
    Communication number: 64-532488 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Mona Fortier, Member of Parliament | Treasury Board Of Canada Secretariat (TBS)
    • Rechie Valdez, Member of Parliament | House of Commons

    Subject Matter of the communication: Health
    Communication date: 2022-04-13
    Posted date: 2022-05-13
    Communication number: 64-531869 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Matthew Jonas, Assistant Deputy Minister | Covid-19 Task Force | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2022-04-12
    Posted date: 2022-05-17
    Communication number: 64-532489 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Sébastien Aubertin-Giguère, Assistant Deputy Minister | Covid-19 Task Force | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2022-03-09
    Posted date: 2022-04-13
    Communication number: 64-528736 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Matthew Jones, Assistant Deputy Minister | Covid-19 Task Force | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2022-03-02
    Posted date: 2022-04-13
    Communication number: 64-528735 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Sébastien Aubertin-Giguère, Assistant Deputy Minister | Covid-19 Task Force | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2022-03-02
    Posted date: 2022-04-13
    Communication number: 64-528733 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Sébastien Aubertin-Giguère, Assistant Deputy Minister | Covid-19 Task Force | Health Canada (HC)
    • Christopher Johnstone, Assistant Deputy Minister | Covid-19 Task Force | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2022-02-24
    Posted date: 2022-03-10
    Communication number: 64-524798 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Sébastien Aubertin-Giguère, Assistant Deputy Minister | Covid-19 Task Force | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2022-02-10
    Posted date: 2022-03-10
    Communication number: 64-524797 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Sandenga Yeba, Senior Policy Advisor - Quebec Desk | Minister's Office | Agriculture and Agri-Food Canada (AAFC)

    Subject Matter of the communication: Health, Industry
    Communication date: 2022-02-03
    Posted date: 2022-03-11
    Communication number: 64-525146 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Mary-Rose Brown, Senior Policy Advisor | Minister's Office | Finance Canada (FIN)

    Subject Matter of the communication: Health, Industry
    Communication date: 2022-02-03
    Posted date: 2022-03-11
    Communication number: 64-525144 (amended from 64-524799) View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Sébastien Aubertin-Giguère, Assistant Deputy Minister | Covid-19 Task Force | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2022-01-27
    Posted date: 2022-02-11
    Communication number: 64-522067 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Sébastien Aubertin-Giguère, Assistant Deputy Minister | Covid-19 Task Force | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2022-01-26
    Posted date: 2022-02-11
    Communication number: 64-522066 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Arianne Reza, Associate Deputy Minister | PSPC | Public Services and Procurement Canada (PSPC)
    • Michael Mills, Assistant Deputy Minister | PSPC | Public Services and Procurement Canada (PSPC)

    Subject Matter of the communication: Health
    Communication date: 2022-01-24
    Posted date: 2022-02-11
    Communication number: 64-522065 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Justin Trudeau, Prime Minister of Canada | Prime Minister's Office (PMO)

    Subject Matter of the communication: Health
    Communication date: 2022-01-18
    Posted date: 2022-02-11
    Communication number: 64-522064 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Arianne Reza, Associate Deputy Minister | PSPC | Public Services and Procurement Canada (PSPC)
    • Michael Mills, Assistant Deputy Minister | PSPC | Public Services and Procurement Canada (PSPC)

    Subject Matter of the communication: Health
    Communication date: 2022-01-17
    Posted date: 2022-02-11
    Communication number: 64-522063 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Arianne Reza, Associate Deputy Minister | PSPC | Public Services and Procurement Canada (PSPC)
    • Michael Mills, Assistant Deputy Minister | PSPC | Public Services and Procurement Canada (PSPC)

    Subject Matter of the communication: Health
    Communication date: 2022-01-14
    Posted date: 2022-02-11
    Communication number: 64-522062 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Sébastien Aubertin-Giguère, Assistant Deputy Minister | Covid-19 Task Force | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2022-01-13
    Posted date: 2022-02-11
    Communication number: 64-522061 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Michael Mills, Assistant Deputy Minister | PSPC | Public Services and Procurement Canada (PSPC)

    Subject Matter of the communication: Health
    Communication date: 2022-01-05
    Posted date: 2022-02-11
    Communication number: 64-522060 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Sébastien Aubertin-Giguère, Assistant Deputy Minister, Covid-19 Testing, Contact Tracing and Data Management Strategies | Covid-19 Task Force | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2021-12-30
    Posted date: 2022-01-17
    Communication number: 64-520241 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Sébastien Aubertin-Giguère, Assistant Deputy Minister, Covid-19 Testing, Contact Tracing and Data Management Strategies | Covid-19 Task Force | Health Canada (HC)
    • Michael Mills, Assistant Deputy Minister | PSPC | Public Services and Procurement Canada (PSPC)

    Subject Matter of the communication: Health
    Communication date: 2021-12-22
    Posted date: 2022-01-17
    Communication number: 64-520240 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Michael Mills, Assistant Deputy Minister | PSPC | Public Services and Procurement Canada (PSPC)
    • Sébastien Aubertin-Giguère, Assistant Deputy Minister, Covid-19 Testing, Contact Tracing and Data Management Strategies | Covid-19 Task Force | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2021-12-10
    Posted date: 2022-01-17
    Communication number: 64-520238 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Michael Mills, Assistant Deputy Minister | PSPC | Public Services and Procurement Canada (PSPC)

    Subject Matter of the communication: Health
    Communication date: 2021-12-07
    Posted date: 2022-01-17
    Communication number: 64-520237 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Sébastien Aubertin-Giguère, Assistant Deputy Minister, Covid-19 Testing, Contact Tracing and Data Management Strategies | Covid-19 Task Force | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2021-12-02
    Posted date: 2022-01-17
    Communication number: 64-520236 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Sébastien Aubertin-Giguère, Assistant Deputy Minister, Covid-19 Testing, Contact Tracing and Data Management Strategies | Covid-19 Task Force | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2021-11-29
    Posted date: 2021-12-13
    Communication number: 64-517040 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Jean-Sébastien Bock, Director of Policy | Minister's Office | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2021-11-26
    Posted date: 2021-12-13
    Communication number: 64-517030 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Dylan Marando, Senior Policy Advisor | Minister's Office | Employment and Social Development Canada (ESDC)

    Subject Matter of the communication: Industry
    Communication date: 2021-11-25
    Posted date: 2021-12-13
    Communication number: 64-517027 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Sébastien Aubertin-Giguère, Assistant Deputy Minister, Covid-19 Testing, Contact Tracing and Data Management Strategies | Covid-19 Task Force | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2021-11-24
    Posted date: 2021-12-13
    Communication number: 64-517038 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Sébastien Aubertin-Giguère, Assistant Deputy Minister, Covid-19 Testing, Contact Tracing and Data Management Strategies | Covid-19 Task Force | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2021-11-23
    Posted date: 2021-12-13
    Communication number: 64-517037 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Sébastien Aubertin-Giguère, Assistant Deputy Minister, Covid-19 Testing, Contact Tracing and Data Management Strategies | Covid-19 Task Force | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2021-11-17
    Posted date: 2021-12-13
    Communication number: 64-517036 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Sébastien Aubertin-Giguère, Assistant Deputy Minister, Covid-19 Testing, Contact Tracing and Data Management Strategies | Covid-19 Task Force | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2021-11-03
    Posted date: 2021-12-13
    Communication number: 64-517035 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Sébastien Aubertin-Giguère, Assistant Deputy Minister, Covid-19 Testing, Contact Tracing and Data Management Strategies | Covid-19 Task Force | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2021-11-02
    Posted date: 2021-12-13
    Communication number: 64-517034 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Rechie Valdez, Member of Parliament | Prime Minister's Office (PMO)

    Subject Matter of the communication: Economic Development
    Communication date: 2021-10-21
    Posted date: 2021-11-08
    Communication number: 64-515146 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Sébastien Aubertin-Giguère, Assistant Deputy Minister, Covid-19 Testing, Contact Tracing and Data Management Strategies | Covid-19 Task Force | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2021-10-15
    Posted date: 2021-11-08
    Communication number: 64-515145 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Sébastien Aubertin-Giguère, Assistant Deputy Minister, Covid-19 Testing, Contact Tracing and Data Management Strategies | Covid-19 Task Force | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2021-10-12
    Posted date: 2021-11-08
    Communication number: 64-515144 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Sébastien Aubertin-Giguère, Assistant Deputy Minister, Covid-19 Testing, Contact Tracing and Data Management Strategies | Covid-19 Task Force | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2021-10-08
    Posted date: 2021-11-08
    Communication number: 64-515143 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Sébastien Aubertin-Giguère, Assistant Deputy Minister, Covid-19 Testing, Contact Tracing and Data Management Strategies | Covid-19 Task Force | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2021-10-07
    Posted date: 2021-11-08
    Communication number: 64-515141 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Sébastien Aubertin-Giguère, Assistant Deputy Minister, Covid-19 Testing, Contact Tracing and Data Management Strategies | Covid-19 Task Force | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2021-10-01
    Posted date: 2021-11-08
    Communication number: 64-515142 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Sébastien Aubertin-Giguère, Assistant Deputy Minister, Covid-19 Testing, Contact Tracing and Data Management Strategies | Covid-19 Task Force | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2021-09-27
    Posted date: 2021-10-13
    Communication number: 64-514548 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Sébastien Aubertin-Giguère, Assistant Deputy Minister, Covid-19 Testing, Contact Tracing and Data Management Strategies | Covid-19 Task Force | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2021-09-24
    Posted date: 2021-10-13
    Communication number: 64-514547 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Sébastien Aubertin-Giguère, Assistant Deputy Minister, Covid-19 Testing, Contact Tracing and Data Management Strategies | Covid-19 Task Force | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2021-09-23
    Posted date: 2021-10-13
    Communication number: 64-514546 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Sébastien Aubertin-Giguère, Assistant Deputy Minister, Covid-19 Testing, Contact Tracing and Data Management Strategies | Covid-19 Task Force | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2021-09-22
    Posted date: 2021-10-13
    Communication number: 64-514545 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Sébastien Aubertin-Giguère, Assistant Deputy Minister, Covid-19 Testing, Contact Tracing and Data Management Strategies | Covid-19 Task Force | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2021-09-22
    Posted date: 2021-10-13
    Communication number: 64-514544 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Sébastien Aubertin-Giguère, Assistant Deputy Minister, Covid-19 Testing, Contact Tracing and Data Management Strategies | Covid-19 Task Force | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2021-09-10
    Posted date: 2021-10-13
    Communication number: 64-514542 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Sébastien Aubertin-Giguère, Assistant Deputy Minister, Covid-19 Testing, Contact Tracing and Data Management Strategies | Covid-19 Task Force | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2021-09-03
    Posted date: 2021-10-13
    Communication number: 64-514540 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Sébastien Aubertin-Giguère, Assistant Deputy Minister, Covid-19 Testing, Contact Tracing and Data Management Strategies | Covid-19 Task Force | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2021-08-27
    Posted date: 2021-09-12
    Communication number: 64-513796 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Sébastien Aubertin-Giguère, Assistant Deputy Minister, Covid-19 Testing, Contact Tracing and Data Management Strategies | Covid-19 Task Force | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2021-08-26
    Posted date: 2021-09-12
    Communication number: 64-513795 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Michael Mills, Assistant Deputy Minister | PSPC | Public Services and Procurement Canada (PSPC)

    Subject Matter of the communication: Industry
    Communication date: 2021-08-11
    Posted date: 2021-09-12
    Communication number: 64-513794 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Sébastien Aubertin-Giguère, Assistant Deputy Minister, Covid-19 Testing, Contact Tracing and Data Management Strategies | Covid-19 Task Force | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2021-07-27
    Posted date: 2021-08-12
    Communication number: 64-512716 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Sébastien Aubertin-Giguère, Assistant Deputy Minister, Covid-19 Testing, Contact Tracing and Data Management Strategies | Covid-19 Task Force | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2021-07-15
    Posted date: 2021-08-12
    Communication number: 64-512714 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Patrick Weiler, Member of Parliament | House of Commons

    Subject Matter of the communication: Health
    Communication date: 2021-07-08
    Posted date: 2021-08-12
    Communication number: 64-512719 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Nipun Vats, Assistant Deputy Minister | Innovation, Science and Economic Development Canada (ISED)
    • Eric Costen, Assistant Deputy Minister | Innovation, Science and Economic Development Canada (ISED)
    • Sheryl Groeneweg, Director General, Manufacturing and Life Sciences Branc | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Science and Technology
    Communication date: 2021-06-30
    Posted date: 2021-07-13
    Communication number: 64-510170 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Sébastien Aubertin-Giguère, Assistant Deputy Minister | Covid-19 Testing, Contact Tracing and Data Management Strategies | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2021-06-17
    Posted date: 2021-07-13
    Communication number: 64-510176 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Tim Singer, Assistant Deputy Minister | Covid-19 Testing, Contact Tracing and Data Management Strategies | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2021-06-03
    Posted date: 2021-07-13
    Communication number: 64-510174 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Sébastien Aubertin-Giguère, Assistant Deputy Minister | Covid-19 Testing, Contact Tracing and Data Management Strategies | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2021-06-03
    Posted date: 2021-07-13
    Communication number: 64-510172 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Ryan Hum, Assistant Deputy Minister | Covid-19 Testing, Contact Tracing and Data Management Strategies | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2021-06-03
    Posted date: 2021-07-13
    Communication number: 64-510171 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Simon Kennedy, Deputy Minister | Innovation, Science and Economic Development Canada (ISED)
    • Mark Schaan, Assistant Deputy Minister, Strategy & Innovation Policy Sector | Innovation, Science and Economic Development Canada (ISED)
    • Nipun Vats, Assistant Deputy Minister, Science and Research | Innovation, Science and Economic | Innovation, Science and Economic Development Canada (ISED)
    • Sheryl Groeneweg, Director General, Manufacturing and Life Sciences Branc | Innovation, Science and Economic Development Canada (ISED)
    • Francis Bilodeau, Assistant Deputy Minister,Strategy & Innovation Policy Sector | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Industry
    Communication date: 2021-05-27
    Posted date: 2021-06-10
    Communication number: 64-507339 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Marcus Powlowski, Member of Parliament | House of Commons

    Subject Matter of the communication: Health
    Communication date: 2021-05-27
    Posted date: 2021-06-10
    Communication number: 64-507338 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Charles Vincent, Assistant Deputy Minister | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Science and Technology
    Communication date: 2021-05-27
    Posted date: 2021-06-10
    Communication number: 64-507337 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Stefania Trombetti, Assistant Deputy Minister | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2021-05-27
    Posted date: 2021-06-10
    Communication number: 64-507336 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Pierre Sabourin, Assistant Deputy Minister | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2021-05-27
    Posted date: 2021-06-10
    Communication number: 64-507335 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Ryan Hum, Assistant Deputy Minister, Covid-19 Testing, Contact Tracing and Data Managmenet | Covid-19 Task Force | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2021-05-20
    Posted date: 2021-06-10
    Communication number: 64-507334 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Mary Ng, Minister of Small Business, Export Promotion and International Trade | Global Affairs Canada (GAC)
    • Jason Easton, Chief of Staff, Minister of Small Business. Export Promotion and International Trade | Global Affairs Canada (GAC)

    Subject Matter of the communication: Industry
    Communication date: 2021-05-12
    Posted date: 2021-06-10
    Communication number: 64-507333 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • François-Philippe Champagne, Minister of Innovation Science & Industry | Minister's Office | Innovation, Science and Economic Development Canada (ISED)
    • Amanda Woodley, Policy, Advisor, Office of the Minister | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Internal Trade, Intellectual Property, Health, Industry
    Communication date: 2021-04-29
    Posted date: 2021-05-12
    Communication number: 64-504281 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Andrew Lui, Member's Assistant | House of Commons

    Subject Matter of the communication: Health
    Communication date: 2021-04-27
    Posted date: 2021-05-12
    Communication number: 64-504277 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Monique Frison, Assistant Deputy Minister, Covid-19 Testing, Contact Tracing and Data Management Strategies | Covid-19 Task Force | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2021-04-22
    Posted date: 2021-05-12
    Communication number: 64-504284 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • François-Philippe Champagne, Minister of Innovation Science & Industry | Minister's Office | Innovation, Science and Economic Development Canada (ISED)
    • Simon Kennedy, Deputy Minister, Innovation Science & Economic Development | Innovation, Science and Economic Development Canada (ISED)
    • David Hurl, Director of Policy, Office of the Minister | Innovation, Science and Economic Development Canada (ISED)
    • Amanda Woodley, Policy Advisor, Office of the Minister | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Industry
    Communication date: 2021-04-21
    Posted date: 2021-05-12
    Communication number: 64-504276 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Monique Frison, Assistant Deputy Minister, Covid-19 Testing, Contact Tracing and Data Management Strategies | Covid-19 Task Force | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2021-04-08
    Posted date: 2021-05-12
    Communication number: 64-504283 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Monique Frison, Assistant Deputy Minister, Covid-19 Testing, Contact Tracing and Data Managmenet | Covid-19 Task Force | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2021-03-26
    Posted date: 2021-04-12
    Communication number: 64-501207 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Michael Mills, Assistant Deputy Minister | PSPC | Public Services and Procurement Canada (PSPC)

    Subject Matter of the communication: Industry
    Communication date: 2021-03-26
    Posted date: 2021-04-12
    Communication number: 64-501205 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Monique Frison, Assistant Deputy Minister, Covid-19 Testing, Contact Tracing and Data Managmenet | Covid-19 Task Force | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2021-03-25
    Posted date: 2021-04-12
    Communication number: 64-501203 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Monique Frison, Assistant Deputy Minister, Covid-19 Testing, Contact Tracing and Data Managmenet | Covid-19 Task Force | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2021-03-12
    Posted date: 2021-04-12
    Communication number: 64-501200 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Michael Mills, Assisstant Deputy Minister | PSPC | Public Services and Procurement Canada (PSPC)

    Subject Matter of the communication: Industry
    Communication date: 2021-03-02
    Posted date: 2021-04-12
    Communication number: 64-501196 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Boyan Gerasimov, Director of Policy | Public Services and Procurement Canada (PSPC)

    Subject Matter of the communication: Health
    Communication date: 2021-02-23
    Posted date: 2021-03-07
    Communication number: 64-497491 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Sabina Saini, Chief of Staff | Minister's office | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2021-02-19
    Posted date: 2021-03-07
    Communication number: 64-497489 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Michael Mills, Assistant Deputy Minister | Public Services and Procurement Canada (PSPC)

    Subject Matter of the communication: Industry
    Communication date: 2021-02-17
    Posted date: 2021-03-07
    Communication number: 64-497495 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Michael Mills, Assistant Deputy Minister | Public Services and Procurement Canada (PSPC)

    Subject Matter of the communication: Industry
    Communication date: 2021-02-16
    Posted date: 2021-03-07
    Communication number: 64-497494 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Les Linklater, Federal Lead, Covid-19 Testing, Contact Tracing and Data Management Strategies | Covid-19 Task Force Ministry of Health | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2021-02-11
    Posted date: 2021-03-07
    Communication number: 64-497493 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Michael Mills, Assistant Deputy Minister | Public Services and Procurement Canada (PSPC)

    Subject Matter of the communication: Industry
    Communication date: 2021-02-02
    Posted date: 2021-03-07
    Communication number: 64-497492 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Michael Mills, Assistant Deputy Minister | PSPC | Public Services and Procurement Canada (PSPC)

    Subject Matter of the communication: Industry
    Communication date: 2021-01-27
    Posted date: 2021-02-10
    Communication number: 64-494867 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Anita Anand, Minister | PSPC | Public Services and Procurement Canada (PSPC)
    • Michael Vandergrift, Assistant Deputy Minister | PSPC | Public Services and Procurement Canada (PSPC)

    Subject Matter of the communication: Industry
    Communication date: 2021-01-22
    Posted date: 2021-02-10
    Communication number: 64-494866 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Les Linklater, Federal Lead, Covid-19 Testing, Contact Tracing and Data Management Strategies | Covid-19 Task Force | Health Canada (HC)
    • Monique Frison, Assistant Deputy Minister | Health Canada | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2021-01-14
    Posted date: 2021-02-10
    Communication number: 64-494863 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Michael Mills, Assistant Deputy Minister | Public Services and Procurement Canada (PSPC)

    Subject Matter of the communication: Industry
    Communication date: 2021-01-12
    Posted date: 2021-02-10
    Communication number: 64-494860 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Monique Frison, Assistant Deputy Minister | Health Canada | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2020-12-15
    Posted date: 2021-01-11
    Communication number: 64-492535 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Michael Mills, Assistant Deputy Minister | Public Services and Procurement Canada (PSPC)

    Subject Matter of the communication: Industry
    Communication date: 2020-12-15
    Posted date: 2021-01-08
    Communication number: 64-492514 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Les Linklater, Federal Lead, COVID-19 Testing, Contact Tracing and Management Strategies | COVID-19 Task Force | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2020-11-19
    Posted date: 2020-12-11
    Communication number: 64-490043 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Nancy Hamzawi, Assistant Deputy Minister | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2020-11-19
    Posted date: 2020-12-11
    Communication number: 64-490037 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Les Linklater, Federal Lead, COVID-19 Testing, Contact Tracing and Management Strategies | COVID-19 Task Force | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2020-11-05
    Posted date: 2020-12-11
    Communication number: 64-490041 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Nancy Hamzawi, Assistant Deputy Minister | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2020-11-05
    Posted date: 2020-12-11
    Communication number: 64-489899 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Nancy Hamzawi, Assistant Deputy Minister | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2020-10-22
    Posted date: 2020-11-13
    Communication number: 64-487568 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Nancy Hamzawi, Assistant Deputy Minister | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2020-10-19
    Posted date: 2020-11-13
    Communication number: 64-487567 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Patty Hadju, Minister of Health | Health Canada (HC)
    • Kathryn Nowers, Director of Policy | Health Canada (HC)

    Subject Matter of the communication: Health, Science and Technology, Industry
    Communication date: 2020-10-16
    Posted date: 2020-11-13
    Communication number: 64-487576 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Mona Nemer, Chief Scientific Officer | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2020-10-13
    Posted date: 2020-11-13
    Communication number: 64-487563 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Nancy Hamzawi, Assistant Deputy Minister | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2020-10-05
    Posted date: 2020-11-13
    Communication number: 64-487560 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Michael Mills, Assistant Deputy Minister | Public Services and Procurement Canada (PSPC)

    Subject Matter of the communication: Industry
    Communication date: 2020-10-04
    Posted date: 2020-11-13
    Communication number: 64-487556 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Bud Sambasivam, Senior Policy Advisor | Prime Minister's Office (PMO)

    Subject Matter of the communication: Health, Industry
    Communication date: 2020-10-01
    Posted date: 2020-11-13
    Communication number: 64-487571 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Nancy Hamzawi, Assistant Deputy Minister | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2020-10-01
    Posted date: 2020-11-13
    Communication number: 64-487549 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Patty Hajdu, Minister of Health | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2020-09-28
    Posted date: 2020-10-13
    Communication number: 64-484051 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Bud Sambasivam, Senior Policy Advisor | Prime Minister's Office (PMO)

    Subject Matter of the communication: Health, Industry
    Communication date: 2020-09-23
    Posted date: 2020-10-13
    Communication number: 64-484047 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Nancy Hamzawi, Assistant Deputy Minister | Testing, Tracing and Data Strategy | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2020-09-22
    Posted date: 2020-10-13
    Communication number: 64-484050 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Nancy Hamzawi, Assistant Deputy Minister | Testing, Tracing and Data Strategy | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2020-09-17
    Posted date: 2020-10-13
    Communication number: 64-484045 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Mona Nemer, Chief Science Officer | Office of the Chief Science Advisor | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Health
    Communication date: 2020-09-16
    Posted date: 2020-10-13
    Communication number: 64-484044 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Nancy Hamzawi, Assistant Deputy Minister | Testing, Tracing and Data Strategy | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2020-09-04
    Posted date: 2020-10-13
    Communication number: 64-484043 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Jean-Francois Houle, Vice-President | National Research Council (NRC)

    Subject Matter of the communication: Research and Development
    Communication date: 2020-09-03
    Posted date: 2020-10-13
    Communication number: 64-484036 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Les Linklater, Federal Lead, Covid-19 Testing, Contract Testing & Data Management Strategies | COVID-19 Task Force | Health Canada (HC)
    • Rhonda Kopp, Associate Vice President | Infectious Disease Prevention & Control | Public Health Agency of Canada (PHAC)
    • Tim Singer, Director General | Health Canada (HC)
    • Kelly Taylor, Director General | Data, Partnerships & Innovation Hub | Public Health Agency of Canada (PHAC)

    Subject Matter of the communication: Health
    Communication date: 2020-07-31
    Posted date: 2020-08-14
    Communication number: 64-479822 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • David Boudreau, Executive Director | Medical Devices Directorate | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2020-07-29
    Posted date: 2020-08-14
    Communication number: 64-479817 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • David Boudreau, Executive Director | Medical Devices Directorate | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2020-06-17
    Posted date: 2020-07-14
    Communication number: 64-477579 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • David Boudreau, Director General | Medical Devices Directorate | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2020-04-28
    Posted date: 2020-05-11
    Communication number: 64-472253 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Celia Caira, Policy Advisor | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Health, Industry
    Communication date: 2020-04-28
    Posted date: 2020-05-11
    Communication number: 64-472252 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Pierre Sabourin, Assistant Deputy Minister | Health Products & Food Branch | Health Canada (HC)
    • Marc Mes, Director General | Marketed Health Products Directorate | Health Canada (HC)
    • Celia Lourenco, Director General | Biologic & Radiopharmaceutical Drugs Directorate | Health Canada (HC)
    • David Boudreau, Director General | Medical Devices Directorate | Health Canada (HC)
    • Supriya Sharma, Chief Medical Officer | Health Canada (HC)
    • John Patrick Stewart, Director General | Therapeutic Products Directorate | Health Canada (HC)
    • Tammy Clifford, Vice President, Research Programs | Canadian Institutes of Health Research (CIHR)
    • Roman Szumski, Vice President, Life Sciences | National Research Council (NRC)

    Subject Matter of the communication: Health
    Communication date: 2020-04-28
    Posted date: 2020-05-11
    Communication number: 64-472251 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Pierre Sabourin, Assistant Deputy Minister | Health Products & Food Branch | Health Canada (HC)
    • Emmanuel Kamarianakis, Director General | Investment and Innovation | Global Affairs Canada (GAC)
    • David Boudreau, Director General | Medical Devices Directorate | Health Canada (HC)
    • Charles Vincent, Director General | Automotive, Transportation & Digital Technologies | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Health, Industry
    Communication date: 2020-04-27
    Posted date: 2020-05-11
    Communication number: 64-472248 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • David Boudreau, Director General | Medical Devices Directorate | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2020-04-27
    Posted date: 2020-05-11
    Communication number: 64-472246 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Jesse Fleming, Senior Director, Policy & Engagement | Programs Directorate | Environment and Climate Change Canada (ECCC)
    • James Burns, Director | Digital Technologies Directorate | Innovation, Science and Economic Development Canada (ISED)
    • Dana Curley, Oversight Executive | Digital Investment Oversight Directorate | Treasury Board Of Canada Secretariat (TBS)

    Subject Matter of the communication: Health, Industry
    Communication date: 2020-04-27
    Posted date: 2020-05-11
    Communication number: 64-472240 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • David Boudreau, Director General | Medical Devices Directorate | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2020-04-24
    Posted date: 2020-05-11
    Communication number: 64-472238 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Navdeep Bains, Minister of Innovation, Science and Industry | House of Commons

    Subject Matter of the communication: Health, Industry
    Communication date: 2020-04-10
    Posted date: 2020-05-11
    Communication number: 64-472237 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Amanda Woodley, Policy Advisor | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Health, Industry
    Communication date: 2020-04-09
    Posted date: 2020-05-11
    Communication number: 64-472236 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Gagan Sikand, Member of Parliament, Mississauga-Streetsville | House of Commons

    Subject Matter of the communication: Health, Industry
    Communication date: 2020-04-02
    Posted date: 2020-05-11
    Communication number: 64-472235 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Sheryl Groeneweg, Director General | ISED | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Industry
    Communication date: 2020-03-31
    Posted date: 2020-04-03
    Communication number: 64-469339 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Sheryl Groeneweg, Director General | ISED | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Industry
    Communication date: 2020-03-27
    Posted date: 2020-04-03
    Communication number: 64-469338 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Sarah Hussaini, Director of Policy, Office of the Minister of Innovation, Science and Industry | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Industry
    Communication date: 2020-03-24
    Posted date: 2020-04-03
    Communication number: 64-469334 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • David Boudreau, Executive Director | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2020-03-23
    Posted date: 2020-04-03
    Communication number: 64-469337 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • David Boudreau, Executive Director | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2020-03-16
    Posted date: 2020-04-03
    Communication number: 64-469336 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Sheryl Groeneweg, Director General | ISED | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Industry
    Communication date: 2020-03-15
    Posted date: 2020-04-03
    Communication number: 64-469335 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Greg Fergus, Member of Parliament- Hull-Alymer | House of Commons

    Subject Matter of the communication: Health, Industry
    Communication date: 2020-03-05
    Posted date: 2020-04-03
    Communication number: 64-469331 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Saini Sabina, Chief of Staff to the Minister of Health | Health Canada (HC)

    Subject Matter of the communication: Health, Industry
    Communication date: 2020-02-12
    Posted date: 2020-03-11
    Communication number: 64-466808 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Caroline Seguin, Director of Policy, Office of the Minister of Economic Development and Official Languages | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Health, Industry
    Communication date: 2020-01-28
    Posted date: 2020-02-13
    Communication number: 64-464327 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Woodley Amanda, Policy Advisor, Office of the Minister of Innovation, Science & Industry | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Health, Industry
    Communication date: 2020-01-16
    Posted date: 2020-02-13
    Communication number: 64-464324 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Ryan Dunn, Chief of Staff to the Minister of Innovation, Science & Industry | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Health, Industry
    Communication date: 2020-01-16
    Posted date: 2020-02-13
    Communication number: 64-464323 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Jason Easton, Chief of Staff to the Minister of Small Business, Export Promotion and International Trade | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Health, Industry
    Communication date: 2020-01-15
    Posted date: 2020-02-13
    Communication number: 64-464317 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Gagan Sikand, Member of Parliament, Mississauga-Streetsville | House of Commons

    Subject Matter of the communication: Health, Employment and Training
    Communication date: 2019-08-21
    Posted date: 2019-09-16
    Communication number: 64-459738 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Julie Dabrusin, Member of Parliament | Toronto-Danforth | House of Commons

    Subject Matter of the communication: Health
    Communication date: 2019-07-17
    Posted date: 2019-08-16
    Communication number: 64-458925 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Emmanuel Kamarianakis, Director | Investment and Innovation | Global Affairs Canada (GAC)

    Subject Matter of the communication: Research and Development, Health, Industry
    Communication date: 2019-06-13
    Posted date: 2019-07-15
    Communication number: 64-457481 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Jim Carr, Minister, International Trade Diversification | Global Affairs Canada (GAC)

    Subject Matter of the communication: Research and Development, Health, Industry
    Communication date: 2019-06-13
    Posted date: 2019-07-15
    Communication number: 64-457479 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Christopher Caione, Regional Economic Advisor (Ontario) | Office of the Minister of Innovation, Science and Economic Development | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Economic Development, Industry, Employment and Training
    Communication date: 2019-05-24
    Posted date: 2019-06-12
    Communication number: 64-454893 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Angad Singh Dhillon, Ontario Regional Desk | Prime Minister's Office (PMO)

    Subject Matter of the communication: Economic Development, Industry, Employment and Training
    Communication date: 2019-05-24
    Posted date: 2019-06-12
    Communication number: 64-454892 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Sheryl Groeneweg, Director General | Manufacturing and Life Sciences Branch | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Economic Development, Industry, Employment and Training
    Communication date: 2019-05-23
    Posted date: 2019-06-12
    Communication number: 64-454891 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Tom Kmiec, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Industry
    Communication date: 2019-05-14
    Posted date: 2019-06-12
    Communication number: 64-454890 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Marilyn Gladu, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Industry
    Communication date: 2019-05-09
    Posted date: 2019-06-12
    Communication number: 64-454888 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Amanda Woodley, Policy Advisor | Office of the Minister of Innovation, Science and Economic Development | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Economic Development, Health, Industry, Employment and Training
    Communication date: 2019-05-06
    Posted date: 2019-06-12
    Communication number: 64-454886 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Hilary Travis, Policy Advisor | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Industry, Employment and Training
    Communication date: 2019-04-02
    Posted date: 2019-05-14
    Communication number: 64-451963 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Rodrigo Arancibia, Director, Life Sciences Industries | Manufacturing and Life Sciences Branch | Innovation, Science and Economic Development Canada (ISED)
    • Sheryl Groenweg, Director General | Manufacturing and Life Sciences Branch | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Health, Industry, Economic Development, Employment and Training
    Communication date: 2019-01-31
    Posted date: 2019-02-21
    Communication number: 64-445985 (amended from 64-444450) View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Hilary Travis, Policy Advisor | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Health, Economic Development, Industry, Employment and Training
    Communication date: 2019-01-31
    Posted date: 2019-02-21
    Communication number: 64-445984 (amended from 64-444452) View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Karina Rolland-Sardana, Stakeholder Relations Advisor | Office of the Leader of the Official Opposition | House of Commons

    Subject Matter of the communication: Intellectual Property, Health, Science and Technology, Industry
    Communication date: 2019-01-30
    Posted date: 2019-11-28
    Communication number: 64-460908 (amended from 64-444620) View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Gagan Sikand, Member of Parliament, Mississauga-Streetsville | House of Commons

    Subject Matter of the communication: Health
    Communication date: 2019-01-30
    Posted date: 2019-02-04
    Communication number: 64-444449 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Sheryl Groenweg, Director General | Manufacturing and Life Sciences Branch | Innovation, Science and Economic Development Canada (ISED)
    • Rodrigo Arancibia, Director, Life Sciences Industries | Manufacturing and Life Sciences Branch | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Economic Development, Health, Industry, Employment and Training
    Communication date: 2019-01-21
    Posted date: 2019-02-21
    Communication number: 64-445983 (amended from 64-444447) View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Rodrigo Arancibia, Director, Life Sciences Industries | Manufacturing and Life Sciences Branch | Innovation, Science and Economic Development Canada (ISED)
    • Sheryl Groenweg, Director General | Manufacturing and Life Sciences Branch | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Health, Economic Development, Industry, Employment and Training
    Communication date: 2018-12-20
    Posted date: 2019-02-21
    Communication number: 64-445981 (amended from 64-443420) View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Gagan Sikand, Member of Parliament, Mississauga-Streetsville | House of Commons

    Subject Matter of the communication: Economic Development, Health, Employment and Training
    Communication date: 2018-12-19
    Posted date: 2019-02-21
    Communication number: 64-445982 (amended from 64-443417) View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Dan Alba, Opposition Shadow Minister, Innovation, Science, & Economic Development, Member of Parliament, Central Okanagan-Similkameen | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Health
    Communication date: 2018-12-11
    Posted date: 2019-01-11
    Communication number: 64-443415 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Lloyd Longfield, Member of Parliament, Guelph | Medical Devices Bureau (Anti-Microbial Industry Coalition Advocacy Day) | House of Commons

    Subject Matter of the communication: Health
    Communication date: 2018-12-04
    Posted date: 2019-01-11
    Communication number: 64-443410 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Marilyn Gladu, Opposition Shadow Minister, Health, Member of Parliament, Sarnia-Lambton | House of Commons
    • Karina Rolland-Sardana, Stakeholder Relations Advisor | Office of the Leader of the Official Opposition | House of Commons

    Subject Matter of the communication: Health
    Communication date: 2018-12-03
    Posted date: 2019-11-28
    Communication number: 64-460907 (amended from 64-443411) View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Hilary Travis, Policy Advisor | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Health, Economic Development, Industry, Employment and Training
    Communication date: 2018-11-29
    Posted date: 2019-02-21
    Communication number: 64-445979 (amended from 64-440910) View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Andrea Johnston, Assistant Deputy Minister | Innovation Canada | Innovation, Science and Economic Development Canada (ISED)
    • Joanne Khouryati, Director General | Innovation Canada | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Health, Economic Development, Industry, Employment and Training
    Communication date: 2018-11-09
    Posted date: 2019-02-21
    Communication number: 64-445980 (amended from 64-440909) View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Lloyd Longfield, Member of Parliament, Guelph | House of Commons

    Subject Matter of the communication: Health
    Communication date: 2018-11-06
    Posted date: 2018-12-06
    Communication number: 64-440908 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • David Boudreau, Executive Director | Medical Devices Bureau (Anti-Microbial Industry Coalition Advocacy Day) | Health Canada (HC)
    • Celia Lourenco, Senior Director | Medical Devices Bureau (Anti-Microbial Industry Coalition Advocacy Day) | Health Canada (HC)
    • Hilary Travis, Policy Advisor | Office of the Minister (Anti-Microbial Industry Coalition Advocacy Day) | Innovation, Science and Economic Development Canada (ISED)
    • John Oliver, Member of Parliament | (Anti-Microbial Industry Coalition Advocacy Day) | House of Commons
    • Bill Casey, Member of Parliament | (Anti-Microbial Industry Coalition Advocacy Day) | House of Commons
    • Ron McKinnon, Member of Parliament | (Anti-Microbial Industry Coalition Advocacy Day) | House of Commons
    • Bob Bratina, Member of Parliament | (Anti-Microbial Industry Coalition Advocacy Day) | House of Commons

    Subject Matter of the communication: Health
    Communication date: 2018-10-30
    Posted date: 2018-11-16
    Communication number: 64-439739 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Gagan Sikand, Member of Parliament, Mississauga-Streetsville | House of Commons

    Subject Matter of the communication: Health
    Communication date: 2018-10-23
    Posted date: 2018-11-16
    Communication number: 64-439738 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • David Lametti, Parliament Secretary to the Minister of Innovation Science & Economic Development, Member of Parliament, La Salle-Emard-Verdun | House of Commons

    Subject Matter of the communication: Health
    Communication date: 2018-10-23
    Posted date: 2018-11-16
    Communication number: 64-439736 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Giancarlo Cairo, Chief of Staff | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Health
    Communication date: 2018-10-23
    Posted date: 2018-11-16
    Communication number: 64-439733 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Lloyd Longfield, Member of Parliament, Guelph | House of Commons

    Subject Matter of the communication: Health
    Communication date: 2018-10-23
    Posted date: 2018-11-16
    Communication number: 64-439732 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Patrick Cousineau, Director, Office of Senator Douglas Black | Senate of Canada

    Subject Matter of the communication: Health
    Communication date: 2018-10-23
    Posted date: 2018-11-16
    Communication number: 64-439731 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • John Knubley, Deputy Minister, Innovation, Science & Economic Development | Innovation, Science and Economic Development Canada (ISED)
    • Mark Schaan, Director General | Market Framework Policy Branch | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Health
    Communication date: 2018-10-23
    Posted date: 2018-11-16
    Communication number: 64-439730 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Dan Albas, Opposition Shadow Minister, Innovation Science & Economic Development, Member of Parliament, Central Okanagan - Similkameen - Nicola | House of Commons

    Subject Matter of the communication: Health
    Communication date: 2018-10-23
    Posted date: 2018-11-16
    Communication number: 64-439728 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Hilary Travis, Policy Advisor | Innovation, Science and Economic Development Canada (ISED)
    • David McFarlane, Director of Policy | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Health, Economic Development, Industry, Employment and Training
    Communication date: 2018-10-10
    Posted date: 2019-02-21
    Communication number: 64-445976 (amended from 64-439725) View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Sheryl Groenweg, Director General | Manufacturing and Life Sciences Branch | Innovation, Science and Economic Development Canada (ISED)
    • Rodrigo Arancibia, Director, Life Sciences Industries | Manufacturing and Life Sciences Branch | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Health
    Communication date: 2018-10-10
    Posted date: 2018-11-16
    Communication number: 64-439727 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Frank Baylis, Member of Parliament, Pierrefonds-Dollard | House of Commons

    Subject Matter of the communication: Health
    Communication date: 2018-09-28
    Posted date: 2018-10-15
    Communication number: 64-435837 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Kathryn Nowers, Director of Policy | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2018-09-25
    Posted date: 2018-10-15
    Communication number: 64-435836 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Rick Theis, Policy Advisor, Health | Prime Minister's Office (PMO)

    Subject Matter of the communication: Health
    Communication date: 2018-09-25
    Posted date: 2018-10-15
    Communication number: 64-435834 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Jamie Kippen, Ontario Regional Desk | Prime Minister's Office (PMO)

    Subject Matter of the communication: Health
    Communication date: 2018-09-19
    Posted date: 2018-10-15
    Communication number: 64-435832 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Kathryn Nowers, Director of Policy | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2018-09-13
    Posted date: 2018-10-15
    Communication number: 64-435823 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Karina Rolland-Sardana, Stakeholder Relations Advisor | Office of the Leader of the Offical Opposition | House of Commons

    Subject Matter of the communication: Health
    Communication date: 2018-09-06
    Posted date: 2019-11-28
    Communication number: 64-460909 (amended from 64-435792) View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Emmanuella Lambropoulos, Member of Parliament, Saint-Laurent | House of Commons

    Subject Matter of the communication: Health
    Communication date: 2018-08-29
    Posted date: 2018-09-12
    Communication number: 64-433439 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • David McFarlane, Director of Policy | Innovation, Science and Economic Development Canada (ISED)
    • Parvinder Sachdeva, Senior Policy Advisor | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Health
    Communication date: 2018-08-22
    Posted date: 2018-09-12
    Communication number: 64-433438 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Michael McNair, Executive Director, Cabinet and Legislative Affairs | Prime Minister's Office (PMO)

    Subject Matter of the communication: Health
    Communication date: 2018-07-19
    Posted date: 2018-08-16
    Communication number: 64-432662 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Hilary Travis, Policy Advisor | Office of the Minister | Innovation, Science and Economic Development Canada (ISED)
    • Mathieu Bouchard, Senior Advisor, Quebec | Prime Minister's Office (PMO)
    • Rick Theis, Policy Advisor, Health | Prime Minister's Office (PMO)

    Subject Matter of the communication: Health
    Communication date: 2018-07-12
    Posted date: 2018-08-16
    Communication number: 64-432661 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Sheryl Groenweg, Director General | Manufacturing and Life Sciences Branch | Innovation, Science and Economic Development Canada (ISED)
    • Rodrigo Arancibia, Director | Life Sciences Industries Directorate | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Health
    Communication date: 2018-07-10
    Posted date: 2018-08-16
    Communication number: 64-432660 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Tushar Shankar, Program Lead | Partnership and Business Development | Canadian Institutes of Health Research (CIHR)

    Subject Matter of the communication: Health
    Communication date: 2018-06-29
    Posted date: 2018-07-12
    Communication number: 64-430549 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Dr. Lucye Galant, A/Director | Therapeutic Products Division | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2018-06-18
    Posted date: 2018-07-12
    Communication number: 64-430550 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Marilyn Desrosiers, Manager, Business Development | Partnership and Business Development | Canadian Institutes of Health Research (CIHR)
    • Tushar Shankar, Program Lead | Partnership and Business Development | Canadian Institutes of Health Research (CIHR)

    Subject Matter of the communication: Health
    Communication date: 2018-06-13
    Posted date: 2018-07-12
    Communication number: 64-430547 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Dr. Patrick Stewart, Director General | Therapeutic Products Division | Health Canada (HC)
    • Dr. Celia Lourenco, a/Executive Director | Therapeutic Products Division | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2018-06-12
    Posted date: 2018-07-12
    Communication number: 64-430533 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Ginette Petitpas-Taylor, Minister of Health | Health Canada (HC)
    • Kathryn Nowers, Director of Policy | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2018-06-01
    Posted date: 2018-07-12
    Communication number: 64-430524 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Mark Schaan, Director General | Marketplace Framework Policy Branch | Innovation, Science and Economic Development Canada (ISED)
    • Charles Taillefer, Director | Privacy & Data Protection Policy Directorate | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Health
    Communication date: 2018-05-29
    Posted date: 2018-06-12
    Communication number: 64-428008 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • David Boudreau, Executive Director | Medical Devices Bureau | Health Canada (HC)
    • Celia Lourenco, Senior Director | Medical Devices Bureau | Health Canada (HC)
    • Maria Carballo, Manager, In-Vitro Diagnostics | Medical Devices Bureau | Health Canada (HC)
    • Matthew Ryan, Senior Policy Analyst | Medical Devices Bureau | Health Canada (HC)
    • Colin Foster, Head of Regulatory and Scientific Information Section | Medical Devices Bureau | Health Canada (HC)
    • Sarah Chandler, Manager, Device Licensing Services Division | Medical Devices Bureau | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2018-05-14
    Posted date: 2018-06-12
    Communication number: 64-428029 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Dara McLeod, Deputy Executive Director, Engagement | Office of the Pharmaceuticals Management Strategies | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2018-05-11
    Posted date: 2018-06-12
    Communication number: 64-428006 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Raj Saini, Member of Parliament | Kitchener-Centre | House of Commons

    Subject Matter of the communication: Health
    Communication date: 2018-05-08
    Posted date: 2018-06-12
    Communication number: 64-428007 (amended from 64-428005) View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Sheryl Groeneweg, Director General | Manufacturing & Life Sciences Branch | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Health
    Communication date: 2018-04-20
    Posted date: 2018-05-10
    Communication number: 64-425548 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Tom Kmiec, Member of Parliament | Calgary-Shepard | House of Commons
    • Stephanie Kusie, Member of Parliament | Calgary-Midnapore | House of Commons
    • Earl Dreeshen, Member of Parliament | Red Deer-Mountain View | House of Commons

    Subject Matter of the communication: Health
    Communication date: 2018-04-17
    Posted date: 2018-05-10
    Communication number: 64-425545 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Maximilien Roy, Policy Advisor | Office of the Minister of Finance | House of Commons

    Subject Matter of the communication: Health
    Communication date: 2018-04-10
    Posted date: 2018-05-10
    Communication number: 64-425542 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Tom Kmiec, Member of Parliament | Calgary-Shepard | House of Commons

    Subject Matter of the communication: Health
    Communication date: 2018-03-29
    Posted date: 2018-04-05
    Communication number: 64-423136 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Dane Lloyd, Member of Parliament | Sturgeon River-Parkland | House of Commons

    Subject Matter of the communication: Health
    Communication date: 2018-03-27
    Posted date: 2018-04-05
    Communication number: 64-423135 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Travis Gordon, Policy Advisor | Office of Hon. Ginette Petitpas Taylor, Minister of Health | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2018-03-08
    Posted date: 2018-04-05
    Communication number: 64-423139 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Kim Elmslie, Assistant Deputy Minister | Infectious Disease Prevention and Control | Public Health Agency of Canada (PHAC)
    • Lindsay Noad, Director | Infectious Disease Prevention and Control | Public Health Agency of Canada (PHAC)
    • Michel Perron, Executive Vice-President | External Affairs and Business Development | Canadian Institutes of Health Research (CIHR)
    • Celia Lourenco, Interim Senior Executive Director | Health Products and Food Branch | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2018-03-08
    Posted date: 2018-04-05
    Communication number: 64-423137 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Simon Kennedy, Deputy Minister | Health Canada | Health Canada (HC)
    • Kendal Weber, Associate Assistant Deputy Minister | Health Products & Food Branch | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2018-03-08
    Posted date: 2018-04-05
    Communication number: 64-423133 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Gianluca Cairo, Chief of Staff to Minister of Innovation, Science & Economic Development | Office of the Minister | Innovation, Science and Economic Development Canada (ISED)
    • Hilary Travis, Special Assistant (Policy) | Office of the Minister | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Health
    Communication date: 2018-03-08
    Posted date: 2018-04-05
    Communication number: 64-423126 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Marc Miller, Parliamentary Secretary to the Minister of Transport | House of Commons

    Subject Matter of the communication: Health
    Communication date: 2018-03-07
    Posted date: 2018-04-05
    Communication number: 64-423134 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Janet MacPhee, Account Executive (Life Sciences) | Investor Services | Global Affairs Canada (GAC)
    • Louise Rousseau, Deputy Director | Investor Services | Global Affairs Canada (GAC)

    Subject Matter of the communication: Industry
    Communication date: 2018-02-27
    Posted date: 2018-03-12
    Communication number: 64-421378 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Stephanie Kusie, Member of Parliament | Calgary-Midnapore | House of Commons

    Subject Matter of the communication: Health
    Communication date: 2018-02-14
    Posted date: 2018-03-12
    Communication number: 64-421377 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Marilyn Gladu, Member of Parliament | Sarnia-Lambton | House of Commons

    Subject Matter of the communication: Health
    Communication date: 2018-02-08
    Posted date: 2018-03-12
    Communication number: 64-421376 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Sheryl Groeneweg, Director General | Manufacturing & Life Sciences Branch | Innovation, Science and Economic Development Canada (ISED)
    • Nancy Faraday-Smith, Manager, Life Sciences Industries Directorate | Manufacturing & Life Sciences Branch | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Health
    Communication date: 2018-02-06
    Posted date: 2018-03-12
    Communication number: 64-421371 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Gianluca Cairo, Chief of Staff to Minister of Innovation, Science & Economic Development | Innovation, Science and Economic Development Canada (ISED)
    • David McFarlane, Director of Policy | Innovation, Science and Economic Development Canada (ISED)
    • Hilary Travis, Special Assistant (Policy) | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Health
    Communication date: 2018-02-05
    Posted date: 2018-03-12
    Communication number: 64-421366 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Matt Jeneroux, Member of Parliament | Member of Parliament, Edmonton-Riverbend | House of Commons

    Subject Matter of the communication: Health
    Communication date: 2018-01-31
    Posted date: 2018-02-12
    Communication number: 64-419233 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Raj Saini, Member of Parliament | Member of Parliament, Kitchener Centre | House of Commons

    Subject Matter of the communication: Health
    Communication date: 2018-01-31
    Posted date: 2018-02-12
    Communication number: 64-419232 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Mathieu Bouchard, Senior Advisor | Prime Minister's Office | House of Commons
    • Maxime Dea, Policy Advisor | Health, Science and Innovation | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Health
    Communication date: 2018-01-30
    Posted date: 2018-02-12
    Communication number: 64-419230 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Gagan Sikand, Member of Parliament | Member of Parliament, Mississuaga-Streetsville | House of Commons

    Subject Matter of the communication: Health
    Communication date: 2018-01-30
    Posted date: 2018-02-12
    Communication number: 64-419224 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Eva Nassif, Member of Parliament, Vimy | House of Commons

    Subject Matter of the communication: Health
    Communication date: 2018-01-18
    Posted date: 2018-02-08
    Communication number: 64-418996 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Francesco Sorbara, Member of Parliament | Vaughan - Woodbridge | House of Commons

    Subject Matter of the communication: Health
    Communication date: 2017-12-06
    Posted date: 2018-01-05
    Communication number: 64-417517 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Gina Charos, Director General | Infectious Disease Prevention and Control Branch | Public Health Agency of Canada (PHAC)

    Subject Matter of the communication: Health
    Communication date: 2017-12-04
    Posted date: 2018-01-05
    Communication number: 64-417516 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • David Lametti, Parliamentary Secretary | To the Minister of Innovation, Science and Economic Development | House of Commons

    Subject Matter of the communication: Health
    Communication date: 2017-11-14
    Posted date: 2017-12-06
    Communication number: 64-414744 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Gagan Sikand, Member of Parliament | Mississauga, Streetsville | House of Commons

    Subject Matter of the communication: Health
    Communication date: 2017-11-09
    Posted date: 2017-12-06
    Communication number: 64-414743 (amended from 64-414741) View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Sheryl Groeneweg, Director General | Manufacturing & Life Sciences Branch | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Health
    Communication date: 2017-10-27
    Posted date: 2017-11-06
    Communication number: 64-411430 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Andrew Atkinson, Manager | Emerging Sciences Policy Unit | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2017-10-16
    Posted date: 2017-11-06
    Communication number: 64-411429 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Sheryl Groeneweg, Director General | Manufacturing & Life Science Branch | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Health
    Communication date: 2017-10-16
    Posted date: 2017-11-06
    Communication number: 64-411427 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Gagan Sikand, Member of Parliament | Mississauga-Streetsville | House of Commons

    Subject Matter of the communication: Industry
    Communication date: 2017-09-26
    Posted date: 2017-10-10
    Communication number: 64-409001 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Sony Perron, Senior Assistant Deputy Minister | First Nations and Inuit Health | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2017-09-21
    Posted date: 2017-10-11
    Communication number: 64-409135 (amended from 64-409010) View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Aruna Sadana, Director General, Delivery | First Nations and Inuit Health (FNIHB) | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2017-09-21
    Posted date: 2017-10-10
    Communication number: 64-409019 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Tom Wong, Chief Medical Officer | First Nations and Inuit Health (FNIHB) | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2017-09-21
    Posted date: 2017-10-10
    Communication number: 64-409013 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Gagan Sikand, Member of Parliament | Mississauga-Streetsville | House of Commons

    Subject Matter of the communication: Health
    Communication date: 2017-09-15
    Posted date: 2017-10-11
    Communication number: 64-409143 (amended from 64-408994) View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • David McFarlane, Director of Policy | Science & Economic Development | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Industry
    Communication date: 2017-09-13
    Posted date: 2017-10-10
    Communication number: 64-408993 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Ailish Campbell, ADM & Chief Trade Commissioner | International Business Development, Investment and Innovation | Global Affairs Canada (GAC)

    Subject Matter of the communication: Industry
    Communication date: 2017-09-11
    Posted date: 2017-10-10
    Communication number: 64-408997 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Christopher Berzins, Director of Policy | Minister of International Trade | Global Affairs Canada (GAC)

    Subject Matter of the communication: Industry
    Communication date: 2017-09-11
    Posted date: 2017-10-10
    Communication number: 64-408996 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Steve Verheul, Assistant Deputy Minister | Trade Agreements & Negotiations | Global Affairs Canada (GAC)

    Subject Matter of the communication: Industry
    Communication date: 2017-09-11
    Posted date: 2017-10-10
    Communication number: 64-408995 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Eva Nassif, Member of Parliament | Vimy | House of Commons

    Subject Matter of the communication: Industry
    Communication date: 2017-08-22
    Posted date: 2017-09-11
    Communication number: 64-407552 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Gina Charos, Director | Infectious Disease & Prevention Control Branch | Public Health Agency of Canada (PHAC)

    Subject Matter of the communication: Health
    Communication date: 2017-08-15
    Posted date: 2017-09-11
    Communication number: 64-407559 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Gagan Sikand, Member of Parliament | Mississauga-Streetsville | House of Commons

    Subject Matter of the communication: Industry
    Communication date: 2017-08-09
    Posted date: 2017-09-11
    Communication number: 64-407553 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Douglas Clark, Executive Director | Patented Medicines Prices Review Board | Patented Medicine Prices Review Board (PMPRB)

    Subject Matter of the communication: Health
    Communication date: 2017-07-26
    Posted date: 2017-08-10
    Communication number: 64-406463 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Corinne Guenette, Director, Life Science Industries Directorate | Manufacuring & Life Sciences | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Health
    Communication date: 2017-07-26
    Posted date: 2017-08-10
    Communication number: 64-406460 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • David Lametti, Parliament Secretary | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Health
    Communication date: 2017-07-25
    Posted date: 2017-08-10
    Communication number: 64-406459 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Brian Kaufmann, Senior Policy Analyst | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2017-07-12
    Posted date: 2017-08-10
    Communication number: 64-406457 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Corinne Guenette, Director, Life Science Industries Directorate | Manufacuring & Life Sciences | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Health
    Communication date: 2017-07-06
    Posted date: 2017-08-10
    Communication number: 64-406454 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Corinne Guenette, Director, Life Science Industries Directorate | Manufacturing and Life Science | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Health
    Communication date: 2017-04-05
    Posted date: 2017-05-15
    Communication number: 64-400613 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Louise Rousseau, Deputy Director | Investor Services | Global Affairs Canada (GAC)

    Subject Matter of the communication: Industry
    Communication date: 2017-03-22
    Posted date: 2017-04-12
    Communication number: 64-398516 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Paul Halucha, Assistant Deputy Minister | Industry Sector | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Industry
    Communication date: 2017-03-20
    Posted date: 2017-04-12
    Communication number: 64-398513 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Gagan Sikand, Member of Parliament | House of Commons

    Subject Matter of the communication: Industry
    Communication date: 2017-03-20
    Posted date: 2017-04-12
    Communication number: 64-398507 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • EVA NASSIF, MEMBER OF PARLIAMENT FOR VIMY | House of Commons

    Subject Matter of the communication: Health
    Communication date: 2017-02-27
    Posted date: 2017-03-15
    Communication number: 64-396737 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • LOUISE ROUSSEAU, Director General | INVESTOR SERVICES | Global Affairs Canada (GAC)

    Subject Matter of the communication: Health
    Communication date: 2017-02-22
    Posted date: 2017-03-15
    Communication number: 64-396725 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Mark Schaan, Director General | Marketplace Framework Policy Branch | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Intellectual Property
    Communication date: 2017-01-26
    Posted date: 2017-02-14
    Communication number: 64-393954 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Corinne Guenette, Director, Life Sciences | Life Sciences Industry Directorate | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Industry
    Communication date: 2017-01-12
    Posted date: 2017-02-14
    Communication number: 64-393952 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Gagan Sikan, Member of Paliament - Mississauga Streetsville | House of Commons

    Subject Matter of the communication: Intellectual Property, Research and Development
    Communication date: 2016-12-02
    Posted date: 2016-12-09
    Communication number: 64-389743 (amended from 64-389742) View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Nicole Charron, Senior Policy Advisor | Office of Pharmaceuticals Management Strategies, Strategic Policy Branch | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2016-10-16
    Posted date: 2016-11-15
    Communication number: 64-387658 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Simon Kennedy, Deputy Minister | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2016-04-14
    Posted date: 2016-04-15
    Communication number: 64-374747 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Simon Kennedy, Deputy Minister of Health | Health Canada | Health Canada (HC)
    • Paul Glover, Assistant Deputy Minister of Health | Health Canada | Health Canada (HC)
    • Cathy Parker, Director General | Health Canada | Health Canada (HC)
    • Jean Pruneau, Executive Director | Office of the Pharmaceutical Management Strategies Strategic Policy Branch | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2015-11-27
    Posted date: 2015-12-11
    Communication number: 64-364875 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Paul Glover, Associate Deputy Minister of Health Canada | Health Canada (HC)
    • Simon Kennedy, Deputy Minister | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2015-09-16
    Posted date: 2015-10-13
    Communication number: 64-362086 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • John Knubley, Deputy Minister | Industry Canada
    • Paul Halucha, Associate Assistant Deputy Minister | Strategic Policy Branch | Industry Canada

    Subject Matter of the communication: Intellectual Property, Research and Development
    Communication date: 2015-04-15
    Posted date: 2015-05-14
    Communication number: 64-353859 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Sean Speer, Special Advisor | Prime Minister's Office (PMO)

    Subject Matter of the communication: Health
    Communication date: 2015-02-27
    Posted date: 2015-03-15
    Communication number: 64-349187 (amended from 64-349184) View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Don Davies, Member of Parliament | House of Commons

    Subject Matter of the communication: Intellectual Property, International Trade
    Communication date: 2015-02-24
    Posted date: 2015-03-15
    Communication number: 64-349182 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Rick Theis, Senior Advisor, Issues Management | House of Commons

    Subject Matter of the communication: Health
    Communication date: 2015-02-05
    Posted date: 2015-03-15
    Communication number: 64-349351 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Nicole Charron, Manager | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2015-02-05
    Posted date: 2015-03-15
    Communication number: 64-349349 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Peter Kent, Member of Parliament | House of Commons

    Subject Matter of the communication: Health
    Communication date: 2015-02-04
    Posted date: 2015-03-15
    Communication number: 64-349181 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Don Davies, Member of Parliament | House of Commons
    • Laurin Lui, Member of Parliament | House of Commons
    • Chystia Freeland, Member of Parliament | House of Commons

    Subject Matter of the communication: Intellectual Property
    Communication date: 2015-01-27
    Posted date: 2015-02-13
    Communication number: 64-347354 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • sean speer, Special advisor | Prime Minister's Office (PMO)

    Subject Matter of the communication: Health
    Communication date: 2015-01-22
    Posted date: 2015-02-13
    Communication number: 64-347352 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Judith Bosse, Assisstant Deputy Minister | Health Canada (HC)
    • Rainer Engelhardt, Chief Science | Health Canada (HC)
    • John Knubley, Chief Science Officer | Industry Canada
    • Philip Jennings, Assistant Deputy Minister | Industry Canada

    Subject Matter of the communication: Health
    Communication date: 2014-12-12
    Posted date: 2015-01-12
    Communication number: 64-343460 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • FRANCES HALL, DIRECTOR OF THE PHARMACEUTICAL POLICY | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2014-10-09
    Posted date: 2014-12-15
    Communication number: 64-342065 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • JEAN PRUNEAU, EXECUTIVE DIRECTOR FOR THE OFFICE OF PHAMRMACEUTICAL | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2014-10-09
    Posted date: 2014-12-15
    Communication number: 64-342062 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Jess Weiser, Director of Policy | Minister's Office | Health Canada (HC)

    Subject Matter of the communication: Intellectual Property
    Communication date: 2014-09-09
    Posted date: 2014-10-15
    Communication number: 64-335834 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Alexandra MacEachern, Policy advisor | Industry Canada

    Subject Matter of the communication: Industry
    Communication date: 2014-08-12
    Posted date: 2014-09-15
    Communication number: 64-333564 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Erin O'Toole, Member Of Parliament | House of Commons

    Subject Matter of the communication: Intellectual Property
    Communication date: 2014-07-16
    Posted date: 2014-08-11
    Communication number: 64-331183 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • BOB DECGERT, Member of Parliament | House of Commons

    Subject Matter of the communication: Intellectual Property
    Communication date: 2014-07-16
    Posted date: 2014-08-11
    Communication number: 64-331182 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Phil Harwood, Policy Advisor Fiscal & Economic Affairs | Policy | Prime Minister's Office (PMO)

    Subject Matter of the communication: Economic Development
    Communication date: 2014-06-25
    Posted date: 2014-07-14
    Communication number: 64-329824 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Brad Butt, House of Commons | House of Commons

    Subject Matter of the communication: Labour
    Communication date: 2014-06-19
    Posted date: 2014-07-14
    Communication number: 64-329972 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Mario Miniaci, Ministerial Assistant to Minister of Health | British Columbia Minister of Health | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2014-06-19
    Posted date: 2014-07-14
    Communication number: 64-329971 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Stella Ambler, Member of Parliament | House of Commons | House of Commons

    Subject Matter of the communication: Economic Development, Intellectual Property, Health
    Communication date: 2014-05-05
    Posted date: 2014-06-18
    Communication number: 64-328310 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Brad Butt, Member of Parliament | House of Commons

    Subject Matter of the communication: Intellectual Property, Health
    Communication date: 2014-03-05
    Posted date: 2014-04-15
    Communication number: 64-322266 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Kevin Ogilvie, Senator | Senate of Canada

    Subject Matter of the communication: Economic Development, Health
    Communication date: 2013-12-11
    Posted date: 2014-01-13
    Communication number: 64-312757 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Justin Burrows, Policy Advisor | Office of the Minister | Finance Canada (FIN)
    • Adam Chambers, Director of Policy | Office of the Minister | Finance Canada (FIN)

    Subject Matter of the communication: Economic Development, International Trade
    Communication date: 2013-11-27
    Posted date: 2013-12-16
    Communication number: 64-310996 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Pablo Sobrino, Associate Assistant Deputy Minister | Acquisitions Branch | Public Works and Government Services Canada

    Subject Matter of the communication: Health
    Communication date: 2013-11-13
    Posted date: 2013-12-16
    Communication number: 64-310995 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Marta Morgan, Associate Deputy Minister | Industry Canada

    Subject Matter of the communication: Internal Trade, Health
    Communication date: 2013-11-04
    Posted date: 2013-12-16
    Communication number: 64-310994 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Alayna Johnson, Policy Advisor | Office of the Minister of Industry | Industry Canada

    Subject Matter of the communication: Intellectual Property
    Communication date: 2013-10-21
    Posted date: 2013-11-15
    Communication number: 64-304251 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Adam Chambers, Director of Policy | Office of the Minister of Finance | Finance Canada (FIN)

    Subject Matter of the communication: Intellectual Property
    Communication date: 2013-09-05
    Posted date: 2013-10-15
    Communication number: 64-296758 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Jose Nunez-Melo, Member of Parliament for Laval | House of Commons

    Subject Matter of the communication: Intellectual Property, Health
    Communication date: 2013-07-15
    Posted date: 2013-08-15
    Communication number: 64-286814 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Jon Aitchison, Policy Advisor | Office of the Minister of Industry | Industry Canada

    Subject Matter of the communication: Intellectual Property
    Communication date: 2013-07-05
    Posted date: 2013-08-15
    Communication number: 64-286812 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Judith Seidman, Senator | Senate of Canada

    Subject Matter of the communication: Health
    Communication date: 2013-06-04
    Posted date: 2013-07-15
    Communication number: 64-281050 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Jonathon Aitchison, Policy Advisor | Minister's Office | Industry Canada

    Subject Matter of the communication: Health
    Communication date: 2013-05-28
    Posted date: 2013-06-15
    Communication number: 64-277491 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Brad Butt, Member of Parliament | Mississauga - Streetsville | House of Commons

    Subject Matter of the communication: Health
    Communication date: 2013-05-06
    Posted date: 2013-06-15
    Communication number: 64-277489 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Sean Speer, Director of Policy | Minister's Office | Finance Canada (FIN)

    Subject Matter of the communication: Health
    Communication date: 2013-01-29
    Posted date: 2013-02-15
    Communication number: 64-258512 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Sean O'Leary, Policy Advisor | Industry Canada

    Subject Matter of the communication: Health
    Communication date: 2013-01-23
    Posted date: 2013-02-15
    Communication number: 64-258511 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Phil Harwood, Policy Advisor | Prime Minister's Office (PMO)
    • Dan Dufort, Stakeholder Relations | Prime Minister's Office (PMO)

    Subject Matter of the communication: Health
    Communication date: 2013-01-23
    Posted date: 2013-02-15
    Communication number: 64-258509 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Patrick McIntyre, Senior Policy Advisor | Office of the Minister of State (Science & Technology) | Federal Economic Development Agency for Southern Ontario (FedDev)
    • Jeannie Smith, Chief of Staff | Office of the Minister of State (Science & Technology) | Federal Economic Development Agency for Southern Ontario (FedDev)
    • Thomas Ferguson, Departmental Liaison | Office of the Minister of State (Science & Technology) | Federal Economic Development Agency for Southern Ontario (FedDev)

    Subject Matter of the communication: Health
    Communication date: 2013-01-23
    Posted date: 2013-02-15
    Communication number: 64-258493 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Sean Speer, Director of Policy | Minister's Office | Finance Canada (FIN)
    • Jasmine Brown, Policy Advisor | Minister's Office | Finance Canada (FIN)

    Subject Matter of the communication: Health
    Communication date: 2013-01-23
    Posted date: 2013-02-15
    Communication number: 64-258489 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Sean Speer, Director of Policy | Minister's Office | Finance Canada (FIN)

    Subject Matter of the communication: Economic Development, Health
    Communication date: 2012-12-20
    Posted date: 2013-01-15
    Communication number: 64-254140 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • BRAD BUTT, Member of Parliament | House of Commons

    Subject Matter of the communication: Industry
    Communication date: 2012-09-26
    Posted date: 2012-10-10
    Communication number: 64-239910 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • LEAH CANNING, Director of Policy | Office of the Minister of Health | Health Canada (HC)

    Subject Matter of the communication: Economic Development, Health, Science and Technology, Research and Development
    Communication date: 2012-08-21
    Posted date: 2012-10-10
    Communication number: 64-239909 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Sean O'Leary, Policy Advisor | Office of the Minister of Industry | Industry Canada

    Subject Matter of the communication: Intellectual Property, Science and Technology, Industry
    Communication date: 2012-07-06
    Posted date: 2012-08-15
    Communication number: 64-233649 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Alain Beaudet, President | Canadian Institutes of Health Research (CIHR)

    Subject Matter of the communication: Health, Science and Technology, Industry
    Communication date: 2012-05-25
    Posted date: 2012-06-22
    Communication number: 64-228369 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Andre Bachand, Senior Advisor | Prime Minister's Office (PMO)
    • Phil Harwood, Policy Advisor | Prime Minister's Office (PMO)

    Subject Matter of the communication: Health, Industry
    Communication date: 2012-03-16
    Posted date: 2012-04-25
    Communication number: 64-220168 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Andre Bachand, Senior Advisor | Prime Minister's Office (PMO)
    • Sean Speer, Senior Economic Policy Advisor | Prime Minister's Office (PMO)
    • Andrea Van Vugt, Policy Advisor | Prime Minister's Office (PMO)
    • Phil Harwood, Policy Advisor | Prime Minister's Office (PMO)
    • Stefan Stefanov, Intern | Prime Minister's Office (PMO)

    Subject Matter of the communication: Intellectual Property, International Trade, Health, Industry
    Communication date: 2012-02-28
    Posted date: 2012-03-12
    Communication number: 64-211530 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Aron Seal, Director of Policy | Finance Canada | Prime Minister's Office (PMO)

    Subject Matter of the communication: Intellectual Property, International Trade, Health, Industry
    Communication date: 2012-02-28
    Posted date: 2012-03-12
    Communication number: 64-211528 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Sean O'Leary, Policy Advisor | Industry Canada | Prime Minister's Office (PMO)

    Subject Matter of the communication: Intellectual Property, International Trade, Health, Industry
    Communication date: 2012-02-28
    Posted date: 2012-03-12
    Communication number: 64-211513 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Scott Tessier, Chief of Staff | Health Canada | Prime Minister's Office (PMO)
    • Graham Howell, Policy Advisor | Health Canada | Prime Minister's Office (PMO)

    Subject Matter of the communication: Intellectual Property, International Trade, Health, Industry
    Communication date: 2012-02-21
    Posted date: 2012-03-12
    Communication number: 64-211512 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Jon Feairs, Senior Policy Advisor | Ontario Ministry of Health | Health Canada (HC)

    Subject Matter of the communication: Science and Technology, Research and Development
    Communication date: 2012-02-10
    Posted date: 2012-03-12
    Communication number: 64-211511 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Brad Butt, Member of Parliament | House of Commons
    • Stella Ambler, Member of Parliament | House of Commons
    • Wladyslaw Lizon, Member of Parliament | House of Commons

    Subject Matter of the communication: International Trade
    Communication date: 2012-01-17
    Posted date: 2012-02-21
    Communication number: 64-208907 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Kirsty Duncan, Member of the House of Commons | House of Commons

    Subject Matter of the communication: International Trade
    Communication date: 2011-11-22
    Posted date: 2011-12-16
    Communication number: 64-199735 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Benôit Violette, Senior Policy Advisor | Office of the Minister of State (Science & Technology) | National Research Council (NRC)

    Subject Matter of the communication: Science and Technology, Research and Development
    Communication date: 2011-11-21
    Posted date: 2011-12-13
    Communication number: 64-199731 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Kelvin Ogilvie, Senator | Senate of Canada

    Subject Matter of the communication: Infrastructure
    Communication date: 2011-10-04
    Posted date: 2011-11-18
    Communication number: 64-195544 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Kirsty Duncan, Member of Parliament | Members of the House of Commons

    Subject Matter of the communication: Infrastructure, Industry
    Communication date: 2011-09-21
    Posted date: 2011-10-17
    Communication number: 64-189885 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Brad Butt, Member of Parlianemt | Members of the House of Commons

    Subject Matter of the communication: Infrastructure, Industry
    Communication date: 2011-09-16
    Posted date: 2011-10-17
    Communication number: 64-189884 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Phil Jennings, Associate Deputy Minister | Industry Canada

    Subject Matter of the communication: Industry
    Communication date: 2011-09-12
    Posted date: 2012-02-21
    Communication number: 64-189886 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Phil Jennings, Associate Assitant Deputy Minister | Industry | Industry Canada

    Subject Matter of the communication: Industry
    Communication date: 2011-09-12
    Posted date: 2011-10-17
    Communication number: 64-189868 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Cynthia Tran, Special Assistant | Office of the Minister of State | Industry Canada

    Subject Matter of the communication: Industry
    Communication date: 2011-08-22
    Posted date: 2011-09-12
    Communication number: 64-184984 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Patrick McIntyre, Director of Policy | Office of the Minister of State | Industry Canada

    Subject Matter of the communication: Science and Technology
    Communication date: 2011-08-22
    Posted date: 2011-09-12
    Communication number: 64-184964 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Patrick McIntyre, Director of Policy | Office of the Minister of State | Prime Minister's Office (PMO)

    Subject Matter of the communication: Science and Technology, Industry
    Communication date: 2011-08-22
    Posted date: 2012-02-21
    Communication number: 64-184944 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Robert Dunlap, Asistant Deputy Minister | Industry Canada
    • Robert Dunlap, Assistant Deputy Minister | Industry Canada

    Subject Matter of the communication: Science and Technology, Industry
    Communication date: 2011-03-28
    Posted date: 2011-04-15
    Communication number: 64-170820 (amended from 64-170811) View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Mitch Davies, Associate Ass't Deputy Minister | Industry Canada

    Subject Matter of the communication: Industry
    Communication date: 2011-03-28
    Posted date: 2011-04-15
    Communication number: 64-170818 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Leah Clark, Director General | Industry Canada

    Subject Matter of the communication: Science and Technology, Industry
    Communication date: 2011-03-28
    Posted date: 2011-04-15
    Communication number: 64-170816 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Karen Corkery, Director General | Industry Canada

    Subject Matter of the communication: Industry
    Communication date: 2011-03-28
    Posted date: 2011-04-15
    Communication number: 64-170814 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Leah Canning, Senior Policy Advisor | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2011-03-16
    Posted date: 2011-04-15
    Communication number: 64-170858 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Rob Oliphant, Member of Parliament | Members of the House of Commons

    Subject Matter of the communication: Health
    Communication date: 2011-03-02
    Posted date: 2011-04-15
    Communication number: 64-170808 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Leah Canning, Senior Policy Advisor | Prime Minister's Office (PMO)

    Subject Matter of the communication: Intellectual Property, International Trade, Health, Industry
    Communication date: 2011-03-02
    Posted date: 2011-04-15
    Communication number: 64-170806 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Andrew Kania, Member of Parliament | Members of the House of Commons

    Subject Matter of the communication: Health
    Communication date: 2011-03-01
    Posted date: 2011-04-15
    Communication number: 64-170805 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Frank Valeriote, Member of Parliament | Members of the House of Commons

    Subject Matter of the communication: Health
    Communication date: 2011-03-01
    Posted date: 2011-04-15
    Communication number: 64-170803 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Phil Welford, Chief of Staff | Office of the Minister | Industry Canada

    Subject Matter of the communication: Industry
    Communication date: 2010-11-30
    Posted date: 2010-12-16
    Communication number: 64-162080 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Tony Clement, Minister of Industry | Industry Canada

    Subject Matter of the communication: Taxation and Finance, Industry
    Communication date: 2010-11-29
    Posted date: 2010-12-16
    Communication number: 64-162085 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Patrick Brown Brown, MP | Members of the House of Commons

    Subject Matter of the communication: Health
    Communication date: 2010-11-24
    Posted date: 2010-12-16
    Communication number: 64-162078 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Tim Uppal, MP | Members of the House of Commons

    Subject Matter of the communication: Health
    Communication date: 2010-11-23
    Posted date: 2010-12-16
    Communication number: 64-162079 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Colin Carrie, MP | Members of the House of Commons

    Subject Matter of the communication: Health
    Communication date: 2010-11-22
    Posted date: 2010-12-16
    Communication number: 64-162076 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Regan Watts, Director of Strategic Planning | Office of the Minister of Finance | Finance Canada (FIN)

    Subject Matter of the communication: Taxation and Finance, Industry
    Communication date: 2010-11-19
    Posted date: 2010-12-16
    Communication number: 64-162083 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Jim Flaherty, Minister of Finance | Finance Canada (FIN)

    Subject Matter of the communication: Taxation and Finance, Industry
    Communication date: 2010-11-19
    Posted date: 2010-12-16
    Communication number: 64-162082 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Dave Forestell, Senior Policy Advisor | Prime Minister's Office (PMO)

    Subject Matter of the communication: Intellectual Property, Health
    Communication date: 2010-11-12
    Posted date: 2010-12-16
    Communication number: 64-162074 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Leah Canning, Senior Policy Adivsor | Minister's Office | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2010-11-09
    Posted date: 2010-12-16
    Communication number: 64-162072 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Kelvin Ogilvie, Senator | Senate of Canada

    Subject Matter of the communication: Health
    Communication date: 2010-11-02
    Posted date: 2011-12-07
    Communication number: 64-162086 (amended from 64-162070) View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Bonnie Crombie, Member of Parliament | House of Commons | Members of the House of Commons

    Subject Matter of the communication: Intellectual Property, International Relations, Health, Industry
    Communication date: 2010-10-28
    Posted date: 2010-11-16
    Communication number: 64-159255 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Kirsty Duncan, MP | Members of the House of Commons
    • Patrick Brown, MP | Members of the House of Commons
    • Dave Van Kesteren, MP | Members of the House of Commons
    • John McCallum, MP | Members of the House of Commons
    • Tim Uppal, MP | Members of the House of Commons

    Subject Matter of the communication: Health, Science and Technology
    Communication date: 2010-09-21
    Posted date: 2011-12-07
    Communication number: 64-156835 (amended from 64-156812) View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Dave Forestell, Policy Advisor | Prime Minister's Office (PMO)

    Subject Matter of the communication: Health
    Communication date: 2010-09-14
    Posted date: 2010-10-16
    Communication number: 64-156837 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • David Pierce, Director, Agencies, Boards, and Commissions / FedNor | Office of the Minister of Industry Canada | Industry Canada

    Subject Matter of the communication: Health
    Communication date: 2010-08-24
    Posted date: 2010-09-16
    Communication number: 64-154617 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Graham Howell, Senior Special Assistant | Minister’s Office | Health Canada (HC)

    Subject Matter of the communication: Taxation and Finance, Health
    Communication date: 2010-07-27
    Posted date: 2010-08-16
    Communication number: 64-153486 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Carly Wolff, Issues Management Communications Advisor | Minister's office | Health Canada (HC)

    Subject Matter of the communication: Intellectual Property, Health
    Communication date: 2010-07-21
    Posted date: 2010-08-16
    Communication number: 64-153488 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Leah Canning, Senior Policy Advisor | Minister's office | Health Canada (HC)

    Subject Matter of the communication: Intellectual Property, Health
    Communication date: 2010-07-21
    Posted date: 2010-08-13
    Communication number: 64-153487 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • David Butler-Jones, Chief Public Health Officer | Public Health Agency of Canada (PHAC)

    Subject Matter of the communication: Health
    Communication date: 2010-06-09
    Posted date: 2010-07-16
    Communication number: 64-152128 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Ron Parker, Senior ADM | Industry Sector | Industry Canada

    Subject Matter of the communication: Subsequent Entry Biologics, Health, Biologics
    Communication date: 2010-06-01
    Posted date: 2010-07-16
    Communication number: 64-152127 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Louis Lévesque, Deputy Minister | Foreign Affairs and International Trade Canada (DFAITC)

    Subject Matter of the communication: Subsequent Entry Biologics, Health, Biologics
    Communication date: 2010-06-01
    Posted date: 2010-07-16
    Communication number: 64-152126 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Karen Dodds, ADM | Strategic Policy Branch | Health Canada (HC)

    Subject Matter of the communication: Intellectual Property, International Trade, Health, Science and Technology
    Communication date: 2010-05-31
    Posted date: 2010-07-14
    Communication number: 64-152125 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Ron Parker, SENIOR ADM | Industry Sector | Industry Canada

    Subject Matter of the communication: Intellectual Property, International Trade, Health, Science and Technology
    Communication date: 2010-05-31
    Posted date: 2010-07-14
    Communication number: 64-152124 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Ken Bednarek, Policy Director | Minister's Office | Justice Canada (JC)

    Subject Matter of the communication: Intellectual Property, Health
    Communication date: 2010-05-18
    Posted date: 2010-07-14
    Communication number: 64-152123 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Ken Bednarek, Policy Director | Minister's Office | Justice Canada (JC)

    Subject Matter of the communication: Intellectual Property, Health
    Communication date: 2010-05-18
    Posted date: 2010-06-16
    Communication number: 64-149757 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Alain Beaudet, President | Canadian Institutes of Health Research (CIHR)

    Subject Matter of the communication: Health
    Communication date: 2010-03-10
    Posted date: 2010-04-19
    Communication number: 64-146283 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Frank Plummer, Scientific Director General | National Microbiology Lab | Public Health Agency of Canada (PHAC)

    Subject Matter of the communication: Pandemic Planning
    Communication date: 2010-03-10
    Posted date: 2010-04-19
    Communication number: 64-146282 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Leah Canning, Senior Policy Advisor | Minister's Office | Health Canada (HC)

    Subject Matter of the communication: Pandemic Planning
    Communication date: 2010-01-11
    Posted date: 2010-03-15
    Communication number: 64-142823 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Jane Billings, Senior Assistant Deputy Minister | Planning and Public Health Integration | Public Health Agency of Canada (PHAC)

    Subject Matter of the communication: Pandemic Planning
    Communication date: 2009-10-23
    Posted date: 2009-11-16
    Communication number: 64-128376 View associated registration